image_name
stringlengths 68
68
| type
stringclasses 2
values | gt_table
stringlengths 116
12.6k
|
|---|---|---|
efae2223879f53bdc05495b96d839694a943bd625ef6336988deff0aba8a999c.png | simple | <table><tr><td>Period</td><td>Ticks collected</td><td>Animals inspected</td><td>Infestation rate (%)</td></tr><tr><td>May-June (2014)</td><td>600</td><td>87</td><td>71</td></tr><tr><td>July-August</td><td>370</td><td>77</td><td>69</td></tr><tr><td>September-October</td><td>231</td><td>77</td><td>58</td></tr><tr><td>November-December</td><td>201</td><td>47</td><td>60</td></tr><tr><td>January-February (2015)</td><td>159</td><td>55</td><td>49</td></tr><tr><td>March-April</td><td>377</td><td>75</td><td>64</td></tr><tr><td>Total (over year)</td><td>1,938</td><td>418</td><td>63</td></tr></table> |
2f89a63b360d0a4a24ee43470161b016cd1b774b22d3308eeb932589c72a384c.png | simple | <table><tr><td>Scheme sponsorship</td><td>State</td><td>Recruitment method</td><td>Code</td></tr><tr><td>Private</td><td>Victoria</td><td>Direct contact with researcher</td><td>E1</td></tr><tr><td>Private</td><td>Victoria</td><td>Scheme</td><td>E2</td></tr><tr><td>Private</td><td>Victoria</td><td>Scheme</td><td>E3</td></tr><tr><td>Private</td><td>Victoria</td><td>Scheme</td><td>E4</td></tr><tr><td>Private</td><td>Victoria</td><td>Scheme</td><td>E5</td></tr><tr><td>Private</td><td>Victoria</td><td>Scheme</td><td>E6</td></tr><tr><td>Private</td><td>Queensland</td><td>Scheme</td><td>E7</td></tr><tr><td>Private</td><td>Queensland</td><td>Scheme</td><td>E8</td></tr><tr><td>Private</td><td>Queensland</td><td>Scheme</td><td>E9</td></tr><tr><td>Not-for-profit</td><td>Victoria</td><td>Direct contact with researcher</td><td>E10</td></tr><tr><td>Not-for-profit</td><td>Victoria</td><td>Scheme</td><td>E11</td></tr><tr><td>Not-for-profit</td><td>Victoria</td><td>Scheme</td><td>E12</td></tr><tr><td>Not-for-profit</td><td>Victoria</td><td>Scheme</td><td>E13</td></tr><tr><td>Not-for-profit</td><td>Victoria</td><td>Scheme</td><td>E14</td></tr><tr><td>Not-for-profit</td><td>Victoria</td><td>Scheme</td><td>E15</td></tr><tr><td>Not-for-profit</td><td>Queensland</td><td>Direct contact with researcher</td><td>E16</td></tr></table> |
d31d6e9bf50023046bd5c402428aefb15168e03976ae41337b48cee98843b1b7.png | complex | <table><tr><td></td><td colspan="2"><underline>Model</underline></td><td colspan="5"><underline>Terms</underline></td></tr><tr><td><underline>Overall</underline><underline>Accuracy</underline></td><td><i>R</i><sup>2</sup> =</td><td><i>p</i> <</td><td></td><td>Tones</td><td>Clicks</td><td>Gabors</td><td>Music</td></tr><tr><td>Language ~ Tones + Clicks + Gabors</td><td>0.671</td><td>0.001</td><td>β =</td><td>0.495</td><td>0.505</td><td>0.054</td><td>−</td></tr><tr><td></td><td></td><td></td><td><i>p</i> =</td><td>0.054</td><td>0.155</td><td>0.786</td><td>−</td></tr><tr><td>Language ~ Tones + Clicks + Gabors + Music</td><td>0.919</td><td>6×10<sup>-7</sup></td><td>β =</td><td>0.181</td><td>0.261</td><td>-0.023</td><td>0.655</td></tr><tr><td></td><td></td><td></td><td><i>p</i> =</td><td>0.191</td><td>0.165</td><td>0.822</td><td>3×10<sup>-5</sup></td></tr><tr><td><underline>Sensitivity</underline><underline>(</underline><underline><i>A</i></underline>'<underline>)</underline></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Language ~ Tones + Clicks + Gabors</td><td>0.646</td><td>0.002</td><td>β =</td><td>0.302</td><td>0.435</td><td>0.229</td><td>−</td></tr><tr><td></td><td></td><td></td><td><i>p</i> =</td><td>0.139</td><td>0.119</td><td>0.323</td><td>−</td></tr><tr><td>Language ~ Tones + Clicks + Gabors + Music</td><td>0.923</td><td>5×10<sup>-7</sup></td><td>β =</td><td>0.065</td><td>0.273</td><td>0.071</td><td>0.696</td></tr><tr><td></td><td></td><td></td><td><i>p =</i></td><td>0.525</td><td>0.055</td><td>0.533</td><td>2×10<sup>-5</sup></td></tr><tr><td><underline>Threshold</underline></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Language ~ Tones + Clicks + Gabors</td><td>0.606</td><td>0.004</td><td>β =</td><td>0.636</td><td>0.520</td><td>0.090</td><td>−</td></tr><tr><td></td><td></td><td></td><td><i>p</i> =</td><td>0.068</td><td>0.030</td><td>0.706</td><td>−</td></tr><tr><td>Language ~ Tones + Clicks + Gabors + Music</td><td>0.846</td><td>4×10<sup>-5</sup></td><td>β =</td><td>0.287</td><td>0.092</td><td>0.009</td><td>0.599</td></tr><tr><td></td><td></td><td></td><td><i>p</i> =</td><td>0.220</td><td>0.595</td><td>0.956</td><td>6×10<sup>-4</sup></td></tr></table> |
0a4a4907c7ce81a7e02ca6bd1ad7cd9327d111e8c5ac2212ee47cd9d8b8d9ff9.png | complex | <table><tr><td rowspan="2">Connection Resiliency</td><td colspan="2">Self-Powered WSN</td><td colspan="2">MEDiSN</td></tr><tr><td>Failure Sequences</td><td>Elapsed Time (s)</td><td>Failure Sequences</td><td>Elapsed Time (s)</td></tr><tr><td>1</td><td>24</td><td>1500</td><td>18</td><td>600</td></tr><tr><td>2</td><td>552</td><td>9720</td><td>306</td><td>2160</td></tr><tr><td>3</td><td>12,144</td><td>32,580</td><td>4896</td><td>2820</td></tr></table> |
9e312fd890f8e1df28047fb2ea36a976fbb174bead09d88f406d5184486f5256.png | complex | <table><tr><td>Subscale/Criterion</td><td colspan="3">Factor</td></tr><tr><td></td><td>1</td><td>2</td><td>3</td></tr><tr><td>SAWS critical life experience</td><td>0.047</td><td>0.702</td><td>0.220</td></tr><tr><td>SAWS emotional regulation</td><td>0.165</td><td>0.869</td><td>−0.007</td></tr><tr><td>SAWS reminiscence and reflectiveness</td><td>0.119</td><td>0.814</td><td>−0.230</td></tr><tr><td>SAWS openness</td><td>0.115</td><td>0.410</td><td>0.682</td></tr><tr><td>SAWS humor</td><td>0.174</td><td>0.589</td><td>0.277</td></tr><tr><td>ASTI</td><td>0.303</td><td>0.580</td><td>0.565</td></tr><tr><td>3D-WS reflective dimension</td><td>0.218</td><td>−0.022</td><td>0.782</td></tr><tr><td>3D-WS affective dimension</td><td>−0.016</td><td>0.202</td><td>0.833</td></tr><tr><td>3D-WS cognitive dimension</td><td>0.372</td><td>−0.205</td><td>0.753</td></tr><tr><td>BWP uncertainty</td><td>0.711</td><td>0.209</td><td>−0.123</td></tr><tr><td>BWP value relativism</td><td>0.758</td><td>0.052</td><td>0.127</td></tr><tr><td>BWP contextualism</td><td>0.850</td><td>0.149</td><td>0.104</td></tr><tr><td>BWP factual knowledge</td><td>0.865</td><td>0.093</td><td>0.268</td></tr><tr><td>BWP procedural knowledge</td><td>0.743</td><td>0.133</td><td>0.408</td></tr></table> |
ac04eeaf93be8f6af15c36f5cff7b45543cde19359ba1ff021dfd07ef4b7d788.png | complex | <table><tr><td>Wound Infections</td><td>Non-Wound Infections</td></tr><tr><td>Cellulitis/Abscess (11/31)</td><td>Seromas (20/31)</td></tr><tr><td colspan="2">Pre-Operative Prophylactic Antibiotics</td></tr><tr><td>Cefazolin 8/11 (73%)</td><td>Cefazolin 16/20 (80%)</td></tr><tr><td>Clindamycin 1/11 (9%)</td><td>Clindamycin 3/20 (15%)</td></tr><tr><td>Vancomycin 1/11 (9%) (plus gentamicin)</td><td>Vancomycin 0/20 (0%)</td></tr><tr><td>Unknown 1/11 (9%)</td><td>Unknown 1/20 (5%)</td></tr><tr><td colspan="2">The Relationship between Pre-Operative Antibiotics and Post-Operative Wound Cultures</td></tr><tr><td>Cefazolin (8/11)</td><td>Cefazolin</td></tr><tr><td>associated isolates *:</td><td>associated isolates *:</td></tr><tr><td>MSSA = 3</td><td>CoNS = 6</td></tr><tr><td>MRSA = 2</td><td>MSSA = 1</td></tr><tr><td><i>M. fortuitum</i> = 1</td><td>VSE = 1</td></tr><tr><td>Unknown = 2</td><td><i>E. coli</i> = 2</td></tr><tr><td>Clindamycin</td><td><i>Proteus</i> sp. = 1</td></tr><tr><td>associated isolates:</td><td>Unknown = 2</td></tr><tr><td><i>E. coli</i> = 7</td><td>Culture negative = 7</td></tr><tr><td>Vancomycin (1/11) (plus gentamicin)</td><td>Clindamycin</td></tr><tr><td>associated isolates:</td><td>associated isolates:</td></tr><tr><td><i>K. pneumoniae</i> = 2</td><td>CoNS = 2</td></tr><tr><td></td><td>Culture negative = 2</td></tr></table> |
3284b3b5bf557636f0160c8b3c708f6e6a9e8dc385e4a7f850a18fb53208cd0e.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">CYP transcripts of <i>O. sanctum</i></td><td colspan="2">CYP transcripts of <i>O. basilicum</i></td><td rowspan="2">Functions</td></tr><tr><td><i>Arabidopsis</i>annotation</td><td>Lamiaceae annotation</td><td><i>Arabidopsis</i>annotation</td><td>Lamiaceae annotation</td></tr><tr><td>CYP72A14</td><td>2</td><td>-</td><td>8</td><td>-</td><td>Phenylpropanoid Metabolism</td></tr><tr><td>CYP73A1</td><td>5</td><td>7</td><td>23</td><td>33</td><td>Cinnamate 4-hydroxylase (C4H)</td></tr><tr><td>CYP75B1</td><td>8</td><td>-</td><td>8</td><td>-</td><td>Flavonoid biosynthesis</td></tr><tr><td>CYP81D1</td><td>2</td><td>-</td><td>16</td><td>-</td><td>Phenylpropanoid Metabolism</td></tr><tr><td>CYP81F3</td><td>1</td><td>-</td><td>9</td><td>-</td><td>Phenylpropanoid Metabolism</td></tr><tr><td>CYP84A1</td><td>2</td><td>-</td><td>1</td><td>-</td><td>Coniferaldehyde 5-hydroxylase</td></tr><tr><td>CYP93D1</td><td>-</td><td>-</td><td>1</td><td>-</td><td>Phenylpropanoid Metabolism</td></tr><tr><td>CYP98A3</td><td>12</td><td>-</td><td>25</td><td>-</td><td>4-Coumaryl shikimic/quinic ester 3′-hydroxylase.</td></tr><tr><td>CYP98A14</td><td>-</td><td>16</td><td>-</td><td>46</td><td><i>p</i>-Coumaryl shikimate hydroxylase</td></tr><tr><td>CYP707A2</td><td>5</td><td>-</td><td>4</td><td>-</td><td>Phenylpropanoid Metabolism (abscisic acid 8′-hydroxylase)</td></tr><tr><td>CYP707A3</td><td>12</td><td>-</td><td>13</td><td>-</td><td>Secondary metabolism (abscisic acid 8′-hydroxylase)</td></tr><tr><td>CYP710A1</td><td>3</td><td>-</td><td>7</td><td>-</td><td>Phenylpropanoid Metabolism</td></tr><tr><td>CYP711A1</td><td>1</td><td>-</td><td>1</td><td>-</td><td>Core phenylpropanoid metabolism</td></tr><tr><td>CYP712A1</td><td>-</td><td>-</td><td>2</td><td>-</td><td>Stilbene, coumarine and lignin biosynthesis</td></tr></table> |
5bbf5dce35795cb7db265652b56c9beee6906381424c130d05b472d90dcabe81.png | complex | <table><tr><td>Variable</td><td>All (<i>n</i> = 76)</td><td>Males (<i>n</i> = 36)</td><td>Females (<i>n</i> = 40)</td><td><i>p</i> (Males vs. Females)</td></tr><tr><td>Age (years)</td><td>34.8 ± 10.4</td><td>35 ± 18</td><td>36 ± 18</td><td>0.7549 <sup>a</sup></td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>24.0 ± 2.9</td><td>25.0 ± 2.7</td><td>23.0 ± 2.9</td><td>0.0009<sup>a</sup></td></tr><tr><td colspan="5">Smoking, <i>n</i> (%)</td></tr><tr><td>Current</td><td>0 (0)</td><td>0 (0)</td><td>0 (0)</td><td></td></tr><tr><td>Ever</td><td>18 (24)</td><td>8 (23)</td><td>10 (24)</td><td></td></tr><tr><td>Never</td><td>58 (76)</td><td>27 (77)</td><td>31 (76)</td><td>ns</td></tr><tr><td colspan="5">Use of Se-containing supplements in the past 6 months, <i>n</i> (%)</td></tr><tr><td>Yes</td><td>5 (7)</td><td>3 (9)</td><td>2 (5)</td><td></td></tr><tr><td>No</td><td>71 (93)</td><td>32 (91)</td><td>39 (95)</td><td>ns</td></tr><tr><td colspan="5">Mean plasma Se ± SD (μg/L)</td></tr><tr><td>Baseline</td><td>65.2 ± 16.5</td><td>65.2 ± 16.6</td><td>65.3 ± 16.5</td><td>0.9729 <sup>b</sup></td></tr><tr><td>After two weeks</td><td>101.1 ± 24.5</td><td>98.7 ± 22.8</td><td>103.3 ± 26.1</td><td>0.3907 <sup>a</sup></td></tr><tr><td>After six weeks</td><td>99.1 ± 20.3</td><td>95.0 ± 16.9</td><td>102.7 ± 22.4</td><td>0.0928 <sup>b</sup></td></tr><tr><td>After four weeks of washout</td><td>76.5 ± 15.6</td><td>75.3 ± 15.3</td><td>77.6 ± 16.1</td><td>0.7777 <sup>b</sup></td></tr><tr><td><i>p</i> (ANOVA)</td><td><0.0001</td><td><0.0001</td><td><0.0001</td><td></td></tr></table> |
d0a6c71b114359c42d913129c75a2b750803ce04454f0eaf32805bbd306c1d0a.png | complex | <table><tr><td>Similarity searches</td><td colspan="2">Common molecules</td><td colspan="2">Common scaffolds</td></tr><tr><td></td><td>SF</td><td>GF</td><td>SF</td><td>GF</td></tr><tr><td>1</td><td>3705</td><td>7759</td><td>1821</td><td>3771</td></tr><tr><td>5</td><td>473</td><td>469</td><td>277</td><td>290</td></tr><tr><td>10</td><td>107</td><td>81</td><td>69</td><td>51</td></tr><tr><td>15</td><td>37</td><td>23</td><td>25</td><td>15</td></tr><tr><td>20</td><td>20</td><td>18</td><td>12</td><td>9</td></tr><tr><td>25</td><td>24</td><td>1</td><td>8</td><td>1</td></tr></table> |
f3ee19d469ad97304b924af0c0e5609bd01e15a2935f1da52056bda86cde8911.png | complex | <table><tr><td colspan="5"> </td></tr><tr><td colspan="5">i) 7 weeks old</td></tr><tr><td> </td><td> </td><td>+/+</td><td>m1/+</td><td>m1/m1</td></tr><tr><td colspan="2">No. of transplantation</td><td>9</td><td>24</td><td>10</td></tr><tr><td colspan="2">Tumor developed</td><td>9</td><td>24</td><td>4</td></tr><tr><td colspan="2">Dead or degrading</td><td>0</td><td>0</td><td>6*</td></tr><tr><td colspan="2"><underline>Tumor size</underline></td><td> </td><td> </td><td> </td></tr><tr><td colspan="2">large (1.0 - 2.0 cm)</td><td>8</td><td>24</td><td>0</td></tr><tr><td colspan="2">middle (0.5 - 1.0 cm)</td><td>1</td><td>0</td><td>0</td></tr><tr><td colspan="2">small (< 0.5 cm)</td><td>0</td><td>0</td><td>4</td></tr><tr><td colspan="2"><underline>Differentiation</underline></td><td> </td><td> </td><td> </td></tr><tr><td colspan="2">Ectoderm</td><td>9</td><td>24</td><td>4</td></tr><tr><td colspan="2">Mesoderm</td><td>8</td><td>21</td><td>0</td></tr><tr><td colspan="2">Endoderm</td><td>4</td><td>14</td><td>2</td></tr><tr><td colspan="5">ii) 1 week old</td></tr><tr><td> </td><td> </td><td>+/+</td><td>m1/+</td><td>m1/m1</td></tr><tr><td colspan="2">No. of transplantation</td><td>3</td><td>8</td><td>5</td></tr><tr><td colspan="2">Tumor developed</td><td>3</td><td>7</td><td>5</td></tr><tr><td colspan="2">Dead or degrading</td><td>0</td><td>1</td><td>0</td></tr><tr><td colspan="2"><underline>Tumor size</underline></td><td> </td><td> </td><td> </td></tr><tr><td colspan="2">large (1.0 - 2.0 cm)</td><td>0</td><td>0</td><td>0</td></tr><tr><td colspan="2">middle (0.5 - 1.0 cm)</td><td>2</td><td>5</td><td>0</td></tr><tr><td colspan="2">small (< 0.5 cm)</td><td>1</td><td>2</td><td>5</td></tr><tr><td colspan="2"><underline>Differentiation</underline></td><td> </td><td> </td><td> </td></tr><tr><td colspan="2">Ectoderm</td><td>3</td><td>7</td><td>0</td></tr><tr><td colspan="2">Mesoderm</td><td>2</td><td>5</td><td>0</td></tr><tr><td colspan="2">Endoderm</td><td>2</td><td>4</td><td>0</td></tr></table> |
11b68edf484edb9fb28bc77013f2ade8dda68d2e1ccc2123652135bc9bb6287a.png | simple | <table><tr><td></td><td>dm-7-RR</td><td>RR</td><td>YR</td><td>dm-7-LR</td><td>LR</td><td>LY</td><td>LW</td><td>LF</td><td>Total MC</td></tr><tr><td>average</td><td>47</td><td>780</td><td>230</td><td>41</td><td>1700</td><td>840</td><td>300</td><td>580</td><td>3400</td></tr><tr><td>median</td><td>11</td><td>85</td><td>81</td><td>7.6</td><td>160</td><td>530</td><td>100</td><td>260</td><td>480</td></tr><tr><td>maximum</td><td>170</td><td>4600</td><td>1200</td><td>230</td><td>7900</td><td>2300</td><td>990</td><td>1800</td><td>14,000</td></tr><tr><td>minimum</td><td>4.3</td><td>3.8</td><td>1.2</td><td>0.89</td><td>3.0</td><td>24</td><td>10</td><td>8.0</td><td>26</td></tr><tr><td><i>n</i> detected</td><td>8</td><td>10</td><td>10</td><td>10</td><td>10</td><td>4</td><td>4</td><td>4</td><td>10</td></tr><tr><td><i>n</i> not detected</td><td>2</td><td>0</td><td>0</td><td>0</td><td>0</td><td>6</td><td>6</td><td>6</td><td>0</td></tr></table> |
185b39153b68a4b2096e1e6155d8bbf0e5de0c6c49a5e4c41b971efdfeed4244.png | simple | <table><tr><td>Organism</td><td>Common name</td><td>Group</td><td>Annotation status</td></tr><tr><td>Acanthamoeba castellanii</td><td>Amoeba</td><td>BCM-HGSC<sup>a</sup></td><td>Server set up in progress</td></tr><tr><td>Helicoverpa armigera</td><td>Cotton bollworm</td><td>CSIRO<sup>b</sup></td><td>Server set up and analysis in progress</td></tr><tr><td>Pythium ultimum</td><td>Pythium blight</td><td>GMOD</td><td>Used one contig to teach a GMOD course</td></tr><tr><td>Zea maize</td><td>Corn</td><td>Iowa<sup>c</sup></td><td>Server set up in progress</td></tr><tr><td>Manduca sexta</td><td>Goliath moth</td><td>Kansas<sup>d</sup></td><td>Server set up in progress</td></tr><tr><td>Mayetiola destructor</td><td>Hessian fly</td><td>Kansas</td><td>Server set up and analysis in progress</td></tr><tr><td>Acromyrmex echinatior</td><td>Leaf cutting ant</td><td>Missouri</td><td></td></tr><tr><td>Apis mellifera</td><td>Honey bee</td><td>LBNL/Missouri</td><td>Server is available for ongoing annotation</td></tr><tr><td>Atta cephalotes</td><td>Leaf cutting ant</td><td>Missouri</td><td></td></tr><tr><td>Bombus impatiens</td><td>Eastern bumble bee</td><td>Missouri</td><td>Used internally to test deployment</td></tr><tr><td>Bos taurus</td><td>Cow</td><td>Missouri</td><td>Used internally; new assembly in progress</td></tr><tr><td>Cardiocondyla obscurior</td><td>Ant, tramp species</td><td>Missouri</td><td>Community is currently annotating</td></tr><tr><td>Monodelphis domestica</td><td>Gray, short-tailedopossum</td><td>Missouri</td><td>Server is available for ongoing annotation</td></tr><tr><td>Pogonomyrmex barbatus</td><td>Red harvester ant</td><td>Missouri</td><td>Community is currently annotating</td></tr><tr><td>Varroa destructor</td><td>Varroa mite</td><td>Missouri</td><td>Computational gene prediction has begun</td></tr><tr><td>Wasmannia auropunctata</td><td>Electric ant</td><td>Missouri</td><td>Community is currently annotating</td></tr><tr><td>Pungitius pungitius</td><td>Nine spine stickleback</td><td>Utah<sup>e</sup></td><td>Analysis in progress</td></tr><tr><td>Over 40 species</td><td>Pigeons</td><td>Utah</td><td>Analysis in progress</td></tr></table> |
1ce51fe8e0d3336b966702b0a4fd6bcc6c3485732da8e67dbe27f43bcfe782eb.png | simple | <table><tr><td>Characteristic</td><td>Adjusted Odds Ratio (95% Confidence Interval) for Remaining Uninsured for Entire Year</td></tr><tr><td>Child uninsured >6 months at baseline</td><td>3.8 (1.4, 10.3)</td></tr><tr><td>African-American/black race/ethnicity<sup>a</sup></td><td>2.8 (1.1, 7.3)</td></tr><tr><td>Male child gender</td><td>2.4 (0.97, 5.8)</td></tr><tr><td>Primary caregiver employed</td><td>0.5 (0.2, 1.4)</td></tr><tr><td>Child born in US</td><td>0.2 (0.01, 3.7)</td></tr><tr><td>Combined annual family income below federal poverty threshold</td><td>0.4 (0.1, 1.4)</td></tr></table> |
6a70cc8a84a856cb9253a1001c18310f9a40edd3a520f04b03ea7d427faac171.png | simple | <table><tr><td></td><td>Density (kg/m<sup>3</sup>)</td><td>Thermal conductivity (W/(m °C))</td><td>Conductivity (S/m)</td><td>Specific heat capacity (J/(kg· °C))</td></tr><tr><td>Myocardium</td><td>1200</td><td>0.55</td><td>0.222</td><td>3200</td></tr><tr><td>Blood</td><td>1000</td><td>0.543</td><td>0.667</td><td>4180</td></tr><tr><td>Radiofrequency electrode</td><td>21,500</td><td>71</td><td>4,000,000</td><td>132</td></tr></table> |
c109cc9a485a28c48693c29c4c3c8c4143dc6b0395f867d92e8d0ea8e8f1c37b.png | complex | <table><tr><td>Diet</td><td colspan="2">ALT</td><td colspan="2">AST</td></tr><tr><td> </td><td>Euthyroid</td><td>Thyroid alt</td><td>Euthyroid</td><td>Thyroid alt</td></tr><tr><td>Control</td><td>43.3 ± 24.73 <sup>ab</sup></td><td>38.5 ± 38.50 <sup>b</sup></td><td>151.6 ± 85.46 <sup>a</sup></td><td>94.4 ± 47.99 <sup>a</sup></td></tr><tr><td>Lard 25%</td><td>46.9 ± 13.20 <sup>ab</sup></td><td>39.4 ± 5.70 <sup>ba</sup></td><td>115.1 ± 69.18 <sup>a</sup></td><td>112.3 ± 47.81 <sup>a</sup></td></tr><tr><td>Soy oil 25%</td><td>51.5 ± 11.30 <sup>ab</sup></td><td>46.9 ± 18.82 <sup>ba</sup></td><td>148.7 ± 96.39 <sup>a</sup></td><td>153.9 ± 102.30 <sup>a</sup></td></tr><tr><td>Lard 37%</td><td>46.7 ± 9.06 <sup>a</sup></td><td>48.11 ± 14.89 <sup>ba</sup></td><td>128.6 ± 65.53 <sup>a</sup></td><td>149.8 ± 105.54 <sup>a</sup></td></tr><tr><td>Soy oil 37%</td><td>53.8 ± 12.72 <sup>a</sup></td><td>48.4 ± 10.84 <sup>ba</sup></td><td>143.9 ± 88.59 <sup>a</sup></td><td>121.7 ± 62.99 <sup>a</sup></td></tr></table> |
109fd2c3da6ccd0fdd91a3d5b2ee6997b73741bd869a9fc21b93530a791e08b3.png | complex | <table><tr><td>Sample</td><td>Temperature (<sup>o</sup>C)</td><td><i>K</i><sub>F</sub> (mmol/g/kPa<sup>1/n</sup>)</td><td><i>n</i> (-)</td><td><i>r</i><sup>2</sup> (-)</td></tr><tr><td rowspan="3">ACF</td><td>25</td><td>0.1051</td><td>1.59</td><td>0.9998</td></tr><tr><td>40</td><td>0.0689</td><td>1.48</td><td>0.9998</td></tr><tr><td>55</td><td>0.0490</td><td>1.38</td><td>0.9998</td></tr><tr><td rowspan="3">CN1/ACF</td><td>25</td><td>0.0813</td><td>1.58</td><td>0.9998</td></tr><tr><td>40</td><td>0.0492</td><td>1.46</td><td>0.9998</td></tr><tr><td>55</td><td>0.0315</td><td>1.33</td><td>0.9999</td></tr><tr><td rowspan="3">CN2/ACF</td><td>25</td><td>0.0987</td><td>1.61</td><td>0.9997</td></tr><tr><td>40</td><td>0.0550</td><td>1.43</td><td>0.9999</td></tr><tr><td>55</td><td>0.0336</td><td>1.34</td><td>0.9999</td></tr></table> |
7aa9a1ecff8157fe0df27be513e0401417376eb32d28c54bb54e50377c1643fc.png | simple | <table><tr><td>FGD</td><td>Age range at point of FGD</td><td>Mean age</td><td>No of participants</td><td>Male</td><td>Female</td><td>SCT</td><td>CT</td></tr><tr><td>FGD 1</td><td>13–15</td><td>13.5</td><td>6</td><td>4</td><td>2</td><td>4</td><td>2</td></tr><tr><td>FGD 2</td><td>15–17</td><td>15.7</td><td>7</td><td>2</td><td>5</td><td>5</td><td>2</td></tr><tr><td>FGD 3</td><td>19–24</td><td>21</td><td>7</td><td>4</td><td>3</td><td>2</td><td>5</td></tr><tr><td>FGD 4</td><td>16–20</td><td>18</td><td>5</td><td>2</td><td>3</td><td>2</td><td>3</td></tr></table> |
a7ee48afde8db3e31005bebb4245755781a12786c01f4fb89fb0a6f15740c7d7.png | simple | <table><tr><td>Pool code</td><td>Region: Site</td><td>Elevation (m)</td><td>Coordinates</td><td>Date</td><td>Pool size</td><td>Species</td><td>Virus detected</td></tr><tr><td>T1</td><td>Aegean: Canakkale</td><td>280</td><td>39°29'36.1"N, 26°19'26.7"E</td><td>08/2015</td><td>20</td><td><i>Cx. theileri</i></td><td><i>Culex theileri flavivirus</i></td></tr><tr><td>T2</td><td>Aegean: Canakkale</td><td>280</td><td>39°29'36.1"N, 26°19'26.7"E</td><td>08/2015</td><td>20</td><td><i>Cx. theileri</i></td><td><i>Culex theileri flavivirus</i></td></tr><tr><td>T3</td><td>Thrace: Kirklareli</td><td>80</td><td>41°36'48.6"N, 26°57'56.3"E</td><td>08/2015</td><td>43</td><td><i>Cx. theileri</i></td><td><i>Culex theileri flavivirus</i></td></tr><tr><td>T4</td><td>Thrace: Kirklareli</td><td>80</td><td>41°36'48.3"N, 26°57'56.5"E</td><td>11/2014</td><td>21</td><td><i>Cx. pipiens</i> (<i>s.l</i>.)</td><td><i>Culex theileri flavivirus</i></td></tr><tr><td>T5</td><td>Thrace: Edirne</td><td>206</td><td>41°48'53.7"N, 26°49'00.7"E</td><td>10/2014</td><td>1</td><td><i>Ur. unguiculata</i></td><td>Unknown <i>Flavivirus</i></td></tr><tr><td>T6</td><td>Thrace: Kirklareli</td><td>80</td><td>41°36'48.6"N, 26°57'56.3"E</td><td>07/2014</td><td>52</td><td><i>Ae. caspius</i></td><td><i>Ochlerotatus caspius flavivirus</i></td></tr><tr><td>T7</td><td>Thrace: Kirklareli</td><td>120</td><td>41°40'23.2"N, 26°58'51.1"E</td><td>06/2014</td><td>41</td><td><i>Ae. caspius</i></td><td><i>Ochlerotatus caspius flavivirus</i></td></tr><tr><td>T8</td><td>Thrace: Kirklareli</td><td>80</td><td>41°36'48.3"N, 26°57'56.5"E</td><td>10/2014</td><td>24</td><td><i>Cx.pipiens</i> (<i>s.l</i>.)</td><td>West Nile virus</td></tr><tr><td>T9</td><td>Thrace: Kirklareli</td><td>317</td><td>41°36'48.6"N, 26°57'56.3"E</td><td>08/2014</td><td>7</td><td><i>Cx. theileri</i></td><td><i>Culex theileri flavivirus</i></td></tr><tr><td>T10</td><td>Thrace: Kirklareli</td><td>317</td><td>41°51'48.3"N, 27°00'59.2"E</td><td>08/2014</td><td>1</td><td><i>Cx. theileri</i></td><td><i>Culex theileri flavivirus</i></td></tr><tr><td>T11</td><td>Thrace; Kirklareli</td><td>112</td><td>41°38'12.4"N, 27°10'36.3"E</td><td>07/2014</td><td>3</td><td><i>Cs. annulata</i> (♂)</td><td><i>Flavivirus</i> AV-2011</td></tr></table> |
140dd0f557d35c2ff6ce4339875221b4ba4597ea44468dd462b90669c3fd15ce.png | simple | <table><tr><td></td><td>Basal Metabolic Rate</td><td>Specific Heat</td><td>Blood Perfusion Coeff.</td><td>Thermal Conductivity</td></tr><tr><td></td><td><i>A<sub>o</sub></i></td><td><i>C<sub>p</sub></i></td><td>B</td><td>K</td></tr><tr><td></td><td>[J/(m<sup>3</sup> s)]</td><td>[J/kg °C]</td><td>[J/ (m<sup>3</sup> s °C)]</td><td>[J/m s °C]</td></tr><tr><td>Air </td><td>0</td><td>1000</td><td>0</td><td>0.03</td></tr><tr><td>Blood </td><td>0</td><td>3640</td><td>0</td><td>0.549</td></tr><tr><td>BoneCancellous </td><td>590</td><td>1300</td><td>3300</td><td>0.4</td></tr><tr><td>BoneCortical </td><td>610</td><td>1300</td><td>3400</td><td>0.4</td></tr><tr><td>BrainGreyMatter </td><td>7100</td><td>3700</td><td>40000</td><td>0.57</td></tr><tr><td>BrainWhiteMatter </td><td>7100</td><td>3600</td><td>15925</td><td>0.5</td></tr><tr><td>Cartilage </td><td>1600</td><td>3500</td><td>9000</td><td>0.47</td></tr><tr><td>Cerebellum </td><td>7100</td><td>3700</td><td>40000</td><td>0.57</td></tr><tr><td>CerebroSpinalFluid </td><td>0</td><td>4200</td><td>0</td><td>0.62</td></tr><tr><td>Cornea </td><td>0</td><td>4200</td><td>0</td><td>0.58</td></tr><tr><td>Dura </td><td>860</td><td>2802</td><td>4830</td><td>0.31</td></tr><tr><td>Fat </td><td>300</td><td>2500</td><td>1700</td><td>0.25</td></tr><tr><td>MucousMembrane </td><td>1600</td><td>3300</td><td>9000</td><td>0.43</td></tr><tr><td>Muscle </td><td>690</td><td>3600</td><td>2700</td><td>0.5</td></tr><tr><td>Nerve </td><td>7100</td><td>3500</td><td>40000</td><td>0.46</td></tr><tr><td>Skin Dry </td><td>1620</td><td>3500</td><td>9100</td><td>0.42</td></tr><tr><td>Skin Wet </td><td>1620</td><td>3500</td><td>9100</td><td>0.42</td></tr><tr><td>Tongue<sup>*</sup></td><td>690</td><td>3600</td><td>2700</td><td>0.5</td></tr><tr><td>VitreousHumor </td><td>0</td><td>4200</td><td>0</td><td>0.6</td></tr></table> |
f46c7abed5bd7d673c0065eb5d34ecbc04f8410aaa78a46301cc154bd2e060e7.png | simple | <table><tr><td>Item</td><td>Factor loading</td><td>Description</td><td>Original item no.</td><td>Initial factor</td><td>Mean (<i>SD</i>)</td><td>r<sub>item-total correlation</sub></td></tr><tr><td>1</td><td>0.722</td><td>Cuando tengo deseos intensos de comer, una vez que empiezo no puedo parar. [When I crave something, I know I won't be able to stop eating once I start]</td><td>2</td><td>Lack of control</td><td>3.01 (1.84)</td><td>0.722<sup>**</sup></td></tr><tr><td>2</td><td>0.679</td><td>A veces, cuando como lo que se me antoja, pierdo control y como demasiado. [If I eat what I am craving, I often lose control and eat too much]</td><td>3</td><td>Lack of control</td><td>3.86 (1.85)</td><td>0.687<sup>**</sup></td></tr><tr><td>3</td><td>0.734</td><td>Sin duda alguna, las ganas de comer me hacen pensar cómo voy a conseguirlo [Food cravings invariably make me think of ways to get what I want to eat.]</td><td>5</td><td>Intentions to eat</td><td>2.98 (1.87)</td><td>0.735<sup>**</sup></td></tr><tr><td>4</td><td>0.734</td><td>No hago más que pensar en la comida. [I feel like I have food on my mind all the time]</td><td>6</td><td>Food-related thoughts</td><td>2.29 (1.56)</td><td>0.722<sup>**</sup></td></tr><tr><td>5</td><td>0.650</td><td>A veces me encuentro pensativo preocupado con comida. [I find myself preoccupied with food]</td><td>8</td><td>Food-related thoughts</td><td>2.58 (1.73)</td><td>0.648<sup>**</sup></td></tr><tr><td>6</td><td>0.679</td><td>Cada vez que deseo comer algo en particular me pongo a hacer planes para comer. [Whenever I have cravings, I find myself making plans to eat]</td><td>18</td><td>Intentions to eat</td><td>3.22 (1.89)</td><td>0.685<sup>**</sup></td></tr><tr><td>7</td><td>0.623</td><td>Siento deseos de comer cuando estoy aburrida, enfadada, o triste. [I crave foods when I feel bored, angry, or sad]</td><td>20</td><td>Negative affect</td><td>3.19 (1.85)</td><td>0.634<sup>**</sup></td></tr><tr><td>8</td><td>0.719</td><td>No tengo la fuerza de voluntad de resistir mis deseos de comer lo que se me antoja. [I have no will power to resist my food crave]</td><td>25</td><td>Lack of control</td><td>3.54 (1.99)</td><td>0.724<sup>**</sup></td></tr><tr><td>9</td><td>0.795</td><td>Una vez que me pongo a comer tengo problemas en dejar de comer. [Once I start eating, I have trouble stopping]</td><td>26</td><td>Lack of control</td><td>2.79 (1.87)</td><td>0.788<sup>**</sup></td></tr><tr><td>10</td><td>0.783</td><td>Por mucho que lo intento, no puedo parar de pensar en comer. [I can't stop thinking about eating no matter how hard I try]</td><td>27</td><td>Food-related thoughts</td><td>2.30 (1.66)</td><td>0.771<sup>**</sup></td></tr><tr><td>11</td><td>0.791</td><td>Si me dejo llevar por la tentación de comer pierdo todo mi control. [If I give in to a food craving, all control is lost]</td><td>29</td><td>Lack of control</td><td>2.53 (1.85)</td><td>0.784<sup>**</sup></td></tr><tr><td>12</td><td>0.784</td><td>Cada vez que se me antoja una comida sigo pensando en ella hasta que me la como. [Whenever I have a food craving, I keep on thinking about eating until I actually eat the food]</td><td>31</td><td>Food-related thoughts</td><td>3.08 (1.88)</td><td>0.782<sup>**</sup></td></tr><tr><td>13</td><td>0.779</td><td>Cuando tengo muchas ganas de comer algo estoy obsesionado con comerlo. [If I am craving something, thoughts of eating it consume me]</td><td>32</td><td>Food-related thoughts</td><td>3.02 (1.86)</td><td>0.777<sup>**</sup></td></tr><tr><td>14</td><td>0.633</td><td>A menudo deseo comer cuando siento emociones fuertes. [My emotions often make me want to eat]</td><td>33</td><td>Negative affect</td><td>2.72 (1.79)</td><td>0.638<sup>**</sup></td></tr><tr><td>15</td><td>0.673</td><td>Es difícil resistir la tentación de tomar comidas apetecibles que están a mi alcance. [It is hard for me to resist the temptation to eat appetizing foods that are within reach]</td><td>35</td><td>Cue-depending eating</td><td>3.91 (1.94)</td><td>0.683<sup>**</sup></td></tr></table> |
79254f8dd04a47b387495f4040fe03905ef7cfffa45a5854e31a9909d0237aab.png | simple | <table><tr><td></td><td>Apixaban</td><td>LMWH/VKA/Placebo</td><td>Difference</td><td>Apixaban</td><td>LMWH/VKA</td><td>Difference</td></tr><tr><td>Number of events(total population)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Recurrent VTE and VTE-related death</td><td>514</td><td>577</td><td>−62</td><td>514</td><td>508</td><td>6</td></tr><tr><td><i>VTE-related death</i></td><td><i>63</i></td><td><i>71</i></td><td><i>−8</i></td><td><i>63</i></td><td><i>63</i></td><td><i>0</i></td></tr><tr><td> <i> Recurrent PE</i></td><td><i>130</i></td><td><i>146</i></td><td><i>−16</i></td><td><i>130</i></td><td><i>129</i></td><td><i>1</i></td></tr><tr><td><i>Recurrent DVT</i></td><td><i>321</i></td><td><i>359</i></td><td><i>−39</i></td><td><i>321</i></td><td><i>316</i></td><td><i>5</i></td></tr><tr><td> Major bleeds</td><td>123</td><td>136</td><td>−13</td><td>123</td><td>149</td><td>−26</td></tr><tr><td> CRNM bleed</td><td>603</td><td>631</td><td>−28</td><td>603</td><td>714</td><td>−111</td></tr><tr><td> Treatment discontinuation due to adverse events</td><td>109</td><td>58</td><td>51</td><td>109</td><td>139</td><td>−30</td></tr><tr><td>Costs</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Anticoagulant costs</td><td>£1121</td><td>£98</td><td>£1023</td><td>£1121</td><td>£98</td><td>£1023</td></tr><tr><td> Monitoring and administration costs<sup>a</sup></td><td>£63</td><td>£261</td><td>-£200</td><td>£63</td><td>£446</td><td>-£385</td></tr><tr><td> Event-related costs</td><td>£4069</td><td>£4214</td><td>-£145</td><td>£4069</td><td>£4170</td><td>-£101</td></tr><tr><td>QALYs</td><td>8.488</td><td>8.386</td><td>0.101</td><td>8.488</td><td>8.425</td><td>0.063</td></tr><tr><td>Life-years</td><td>10.421</td><td>10.311</td><td>0.110</td><td>10.421</td><td>10.375</td><td>0.046</td></tr><tr><td>Cost per QALY gained</td><td></td><td>£6692</td><td></td><td></td><td>£8528</td><td></td></tr></table> |
e84cb3cb957a2bdb2e89d0c1fc990f46be013dffea3285c267d249adf0f89668.png | complex | <table><tr><td> </td><td>Participants (n)</td><td>Age mean (SD)</td><td>E-learning interest mean (SD)</td><td>E-learning experience mean (SD)</td></tr><tr><td rowspan="3">Prior clinical knowledge</td><td>Male (18)</td><td>26.16 (4.33)</td><td>4.33 (1.23)</td><td>3.72 (1.13)</td></tr><tr><td>Female (32)</td><td>24.56 (5.49)</td><td>3.94 (1.19)</td><td>3.31 (1.26)</td></tr><tr><td>Total (50)</td><td>25.14 (5.12)</td><td>4.08 (1.21)</td><td>3.46 (1.22)</td></tr><tr><td rowspan="3">No prior clinical knowledge</td><td>Male (18)</td><td>24.00 (2.52)</td><td>4.67 (0.84)</td><td>4.00 (1.28)</td></tr><tr><td>Female (40)</td><td>22.37 (2.64)</td><td>4.15 (1.05)</td><td>3.45 (0.93)</td></tr><tr><td>Total (58)</td><td>22.88 (2.67)</td><td>4.31 (1.01)</td><td>3.62 (1.07)</td></tr></table> |
0577434b3bf12c43c07216b140f517b0c78d0cc70388c11fe82f8eb882d6f24c.png | simple | <table><tr><td>Assay</td><td>LK>LK Ri</td><td>DH44>LK Ri</td><td>DH44>DH44 Ri</td><td>LK>DH44 Ri</td></tr><tr><td>Effect of manipulation</td><td>Global LK knockdown</td><td>LK knockdown in ABLKs</td><td>Global DH44 knockdown</td><td>DH44 knockdown in ABLKs</td></tr><tr><td>Desiccation survival</td><td>↑****</td><td>↑****</td><td>No effect</td><td>↑****</td></tr><tr><td>Starvation survival</td><td>↑****</td><td>↑****</td><td>↑****</td><td>↑****</td></tr><tr><td>Ionic stress survival</td><td>↑****</td><td>↑****</td><td>↑****</td><td>↑****</td></tr><tr><td>Chill coma recovery</td><td>No effect</td><td>↑*</td><td>↑*</td><td>↑*</td></tr><tr><td>Feeding</td><td>No effect</td><td>No effect</td><td>No effect</td><td>↓****</td></tr><tr><td>Water content</td><td>↑**</td><td>↑****</td><td>No effect</td><td>No effect</td></tr></table> |
e2a3c19b4bc8afb4be52574ebbfb02f8160af2f7dfdf7770cf121e461e839a74.png | complex | <table><tr><td></td><td># G</td><td># loc</td><td>PPL</td><td>Br</td><td>Hj (S.E.)</td><td>F<sub>IS</sub></td><td>Filled seeds (%)</td><td>Seed viability (%)</td></tr><tr><td colspan="9"><i>Northwestern European J. communis populations</i></td></tr><tr><td>Cour</td><td>9</td><td>104</td><td>73</td><td>1.73</td><td>0.409 (0.012)</td><td>0.27</td><td>4.41</td><td>0.10</td></tr><tr><td>Heiderbos*</td><td>30</td><td>104</td><td>100</td><td>1.85</td><td>0.337 (0.014)</td><td>0.42</td><td>15.28</td><td>5.49</td></tr><tr><td>Resteigne</td><td>24</td><td>104</td><td>90</td><td>1.65</td><td>0.343 (0.013)</td><td>0.46</td><td>9.47</td><td>5.49</td></tr><tr><td>Cocquerel</td><td>18</td><td>104</td><td>98</td><td>1.93</td><td>0.364 (0.012)</td><td>-0.06</td><td>2.70</td><td>0.44</td></tr><tr><td>Grattepanche</td><td>32</td><td>104</td><td>100</td><td>1.94</td><td>0.386 (0.011)</td><td>0.04</td><td>1.73</td><td>0.58</td></tr><tr><td>Hühnermoor</td><td>33</td><td>104</td><td>94</td><td>1.75</td><td>0.331 (0.014)</td><td>0.47</td><td>11.95</td><td>4.58</td></tr><tr><td>Ecksberg</td><td>12</td><td>104</td><td>96</td><td>1.94</td><td>0.389 (0.012)</td><td>0.00</td><td>11.45</td><td>3.89</td></tr><tr><td>Meenser Heide</td><td>14</td><td>104</td><td>87</td><td>1.82</td><td>0.363 (0.013)</td><td>-0.02</td><td>18.98</td><td>2.76</td></tr><tr><td>Weinberg</td><td>12</td><td>104</td><td>90</td><td>1.86</td><td>0.371 (0.013)</td><td>0.10</td><td>10.02</td><td>4.92</td></tr><tr><td>Boshuizerbergen</td><td>35</td><td>104</td><td>99</td><td>1.75</td><td>0.344 (0.012)</td><td>0.46</td><td>3.80</td><td>1.50</td></tr><tr><td>Kootwijkerzand</td><td>12</td><td>104</td><td>98</td><td>1.93</td><td>0.347 (0.013)</td><td>-0.14</td><td>5.21</td><td>0.48</td></tr><tr><td>Loenen</td><td>21</td><td>104</td><td>98</td><td>1.90</td><td>0.363 (0.011)</td><td>0.22</td><td>6.69</td><td>2.32</td></tr><tr><td>Mantingerzand</td><td>34</td><td>104</td><td>87</td><td>1.91</td><td>0.346 (0.013)</td><td>0.02</td><td>2.70</td><td>0.14</td></tr><tr><td colspan="9"><i>Flemish J. communis populations</i></td></tr><tr><td>Heiderbos*</td><td>57</td><td>94</td><td>100</td><td>1.86</td><td>0.359 (0.012)</td><td>0.37</td><td>NA</td><td>NA</td></tr><tr><td>Kattevennen</td><td>26</td><td>94</td><td>98</td><td>1.86</td><td>0.382 (0.011)</td><td>0.41</td><td>NA</td><td>NA</td></tr><tr><td>Hesselberg</td><td>26</td><td>94</td><td>96</td><td>1.83</td><td>0.364 (0.013)</td><td>0.33</td><td>NA</td><td>NA</td></tr></table> |
5702c2b93de8a373ece1a21fc4ce11277952248a2a24437e51135fb4f3c700ed.png | simple | <table><tr><td></td><td>TE1 (<i>n = </i>24)</td><td>TE2 (<i>n</i> = 22)</td><td>TE3 (<i>n</i> = 30)</td><td>TE4 (<i>n</i> = 25)</td></tr><tr><td>Condition</td><td>D</td><td>CN</td><td>D</td><td>CN</td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td></tr><tr><td> Girls</td><td>11 (45.8%)</td><td>13 (59.1%)</td><td>15 (50.0%)</td><td>15 (60.0%)</td></tr><tr><td> Boys</td><td>13 (54.2%)</td><td>9 (40.9%)</td><td>15 (50.0%)</td><td>10 (40.0%)</td></tr><tr><td>Age, mean (SD)</td><td>10.58 (0.58)</td><td>10.46 (0.67)</td><td>10.43 (0.57)</td><td>10.48 (0.51)</td></tr><tr><td>Race/ethnicity</td><td>23 Latino</td><td>21 Latino</td><td>25 Latino</td><td>22 Latino</td></tr><tr><td></td><td>1 European American</td><td>1 Asian</td><td>3 African American</td><td>2 African American</td></tr><tr><td></td><td></td><td></td><td>2 Filipino</td><td>1 European American</td></tr></table> |
165282f8916b57a8e5736316a348fbd4f0fd27bdc18241c1036aea8bb26b7a54.png | simple | <table><tr><td> </td><td>Daytime</td><td>Nighttime</td><td>24 h</td></tr><tr><td>SBP</td><td> </td><td> </td><td> </td></tr><tr><td><i> Symptomatic</i></td><td>124.7 ± 25.2</td><td>131.2 ± 26.6</td><td>126.7 ± 25.1</td></tr><tr><td><i> Asymptomatic</i></td><td>123.1 ± 13.8</td><td>122.1 ± 19.9</td><td>122.5 ± 14.5</td></tr><tr><td>DBP</td><td> </td><td> </td><td> </td></tr><tr><td><i> Symptomatic</i></td><td>76.6 ± 13.3</td><td>80.3 ± 14.6</td><td>77.7 ± 13.2</td></tr><tr><td><i> Asymptomatic</i></td><td>77.9 ± 12.2</td><td>75.9 ± 10.1</td><td>77.1 ± 11.3</td></tr><tr><td>HR</td><td> </td><td> </td><td> </td></tr><tr><td><i> Symptomatic</i></td><td>78.8 ± 14.7</td><td>74.2 ± 14.4</td><td>77.6 ± 14.4</td></tr><tr><td><i> Asymptomatic</i></td><td>75.9 ± 15.2</td><td>69.7 ± 14.8</td><td>74.5 ± 14.4</td></tr><tr><td>AD event</td><td> </td><td> </td><td> </td></tr><tr><td><i> Symptomatic</i></td><td>2.7 ± 2.0</td><td>3.0 ± 2.9</td><td>5.7 ± 3.5</td></tr><tr><td><i> Asymptomatic</i></td><td>3.3 ± 1.7</td><td>2.7 ± 3.0</td><td>6.0 ± 3.3</td></tr></table> |
59af8ed3b2d87a9a55585d11fb9b523dc89a989fe19c61fa72cdcf5dbb023a41.png | simple | <table><tr><td>Domains</td><td>Patients n = 15</td><td>Controls n = 15</td><td>p-value</td></tr><tr><td>Somatisation</td><td>0.647 (0.496)</td><td>0.357 (0.366)</td><td>0.005 (0.013)</td></tr><tr><td>Obsessive-Compulsive</td><td>0.670 (0.578)</td><td>0.447 (0.253)</td><td>0.14</td></tr><tr><td>Interpersonal sensitivity</td><td>0.453 (0.504)</td><td>0.313 (0.295)</td><td>0.55</td></tr><tr><td>Depression</td><td>0.753 (0.666)</td><td>0.190 (0.167)</td><td>0.01 (0.03)</td></tr><tr><td>Anxiety</td><td>0.40 (0.417)</td><td>0.27 (0.492)</td><td>0.05 (0.09)</td></tr><tr><td>Hostility</td><td>0.42 (0.581)</td><td>0.22 (0.308)</td><td>0.3</td></tr><tr><td>Phobic Anxiety</td><td>0.11 (0.168)</td><td>0.30 (0.082)</td><td>0.08</td></tr><tr><td>Paranoid Ideation</td><td>0.42 (0.64)</td><td>0.16 (0.181)</td><td>0.33</td></tr><tr><td>Psychoticism</td><td>0.19 (0.292)</td><td>0.04 (0.063)</td><td>0.16</td></tr><tr><td>Global severity index</td><td>0.502 (0.444)</td><td>0.243 (0.123)</td><td>0.04 (0.08)</td></tr><tr><td>Positive symptom distress index</td><td>1.0 (1.73)</td><td>3.33 (11.8)</td><td>0.6</td></tr></table> |
1cd4a1b3ce5a89e313d43569cb4c907acb50d78f31f2b3ce0060e1b740d61fb1.png | complex | <table><tr><td>Time of assessment</td><td colspan="4">Survival</td></tr><tr><td></td><td>1 year</td><td>2 years</td><td>3 years</td><td>5 years</td></tr><tr><td>After day 28</td><td>33.0%</td><td>27.0%</td><td>23.9%</td><td>19.8%</td></tr><tr><td>After ICU discharge (male and female)</td><td>61.8%</td><td>50.6%</td><td>44.7%</td><td>37.0%</td></tr><tr><td>After ICU discharge (male)</td><td>64.7%</td><td>53.8%</td><td>46.0%</td><td>37.7%</td></tr><tr><td>After ICU discharge (female)</td><td>53.8%</td><td>41.6%</td><td>41.6%</td><td>36.3%</td></tr><tr><td>General population (male, age 65 years)<sup>a</sup></td><td>98.3%</td><td>96.5%</td><td>94.6%</td><td>90.3%</td></tr><tr><td>General population (female, age 65 years)<sup>a</sup></td><td>99.2%</td><td>98.4%</td><td>97.4%</td><td>95.2%</td></tr></table> |
6b5c56005b1277976b58e369a1b506a9c6fefe939c227f0dce2eac76dbd440d2.png | simple | <table><tr><td></td><td>Antibiotic coated (n=31)</td><td>Antibiotic non-coated (n=40)</td><td>p</td></tr><tr><td>Mean age (years)</td><td>48.5</td><td>51.2</td><td>>0.05</td></tr><tr><td>Positive culture n (%)</td><td>4 (13)</td><td>14 (35)</td><td>0.002</td></tr><tr><td>Median follow-up (months)</td><td>29 (8 to 38)</td><td>53 (14 to 82)</td><td><0.05</td></tr><tr><td>Mean revision time after first implant (years)</td><td>7.1 (2.4 to 8)</td><td>9.4 (0.8 to 17)</td><td><0.05</td></tr></table> |
a6d4b957462d05261f8a107d3ef3bb6d4935100bf18ceb4cab40db0f8433a55d.png | simple | <table><tr><td>Gene</td><td>Gene information</td><td>GO term</td></tr><tr><td>APOLD1</td><td>Apolipoprotein L domain containing 1</td><td>Response to abiotic stimulus</td></tr><tr><td>ATP13A4</td><td>ATPase type 13A4</td><td>Transmembrane transport</td></tr><tr><td>ATP1A2</td><td>ATPase, Na+/K+ transporting, alpha 2 polypeptide</td><td>Behavior / response to abiotic stimulus / transmembrane transport</td></tr><tr><td>CIART</td><td>Circadian associated repressor of transcription</td><td>Behavior</td></tr><tr><td>GJA1</td><td>Gap junction protein, alpha 1, 43 kDa</td><td>Behavior / response to abiotic stimulus / transmembrane transport</td></tr><tr><td>GPR37</td><td>G protein-coupled receptor 37 (endothelin receptor type B-like)</td><td>Behavior</td></tr><tr><td>HIF3A</td><td>Hypoxia inducible factor 3, alpha subunit</td><td>Response to abiotic stimulus</td></tr><tr><td>IGFBP7</td><td>Insulin-like growth factor binding protein 7</td><td>Response to abiotic stimulus</td></tr><tr><td>MLC1</td><td>Megalencephalic leukoencephalopathy with subcortical cysts 1</td><td>Response to abiotic stimulus / transmembrane transport</td></tr><tr><td>PLOD2</td><td>Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2</td><td>Response to abiotic stimulus</td></tr><tr><td>PREX2</td><td>Phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2</td><td>Behavior</td></tr><tr><td>PTN</td><td>Pleiotrophin</td><td>Behavior</td></tr><tr><td>S1PR1</td><td>Sphingosine-1-phosphate receptor 1</td><td>Behavior</td></tr><tr><td>SDC2</td><td>Syndecan 2</td><td>Response to abiotic stimulus</td></tr><tr><td>SDC4</td><td>Syndecan 4</td><td>Response to abiotic stimulus</td></tr><tr><td>SLC14A1</td><td>Urea transporter,Kidd blood group</td><td>Transmembrane transport</td></tr><tr><td>SLC1A2</td><td>Glial high affinity glutamate transporter</td><td>Behavior / response to abiotic stimulus / transmembrane transport</td></tr><tr><td>SLC1A3</td><td>Glial high affinity glutamate transporter</td><td>Behavior / response to abiotic stimulus / transmembrane transport</td></tr><tr><td>SLC4A4</td><td>Sodium bicarbonate cotransporter</td><td>Transmembrane transport</td></tr><tr><td>SLC5A11</td><td>Sodium/inositol cotransporter</td><td>Transmembrane transport</td></tr><tr><td>SLC7A11</td><td>Anionic amino acid transporter light chain, xc- system</td><td>Transmembrane transport</td></tr><tr><td>SLCO1C1</td><td>Solute carrier organic anion transporter</td><td>Transmembrane transport</td></tr><tr><td>TP53BP2</td><td>Tumor protein p53 binding protein 2</td><td>Response to abiotic stimulus</td></tr><tr><td>VEGFA</td><td>Vascular endothelial growth factor A</td><td>Behavior / response to abiotic stimulus</td></tr></table> |
595a34d7b2508e0caa0003c7dfa640f206ec63c2be63a30d16161cc9d327d04f.png | complex | <table><tr><td colspan="4">Data flow stages</td></tr><tr><td>Tool</td><td>SQS</td><td>Action property</td><td>Activity(Yes or No)</td></tr><tr><td colspan="4">Data collection</td></tr><tr><td>Primary self-quantification tools</td><td>Digifit, BodyTrack and Wikilife</td><td>C</td><td>Yes</td></tr><tr><td>Primary self-quantification tools and apps</td><td></td><td>U</td><td>Yes</td></tr><tr><td colspan="4">Data transmission</td></tr><tr><td>Universal Serial Bus (USB) network</td><td>Digifit, BodyTrack and Wikilife</td><td>S</td><td>No</td></tr><tr><td>Application has a feature for importing data</td><td></td><td>U</td><td>Yes</td></tr><tr><td colspan="4">Data storing</td></tr><tr><td>Files (e.g., XML, CSV, etc.)</td><td>Digifit website, BodyTrack and Wikilife</td><td>C</td><td>Yes</td></tr><tr><td>Data aggregation</td><td></td><td></td><td></td></tr><tr><td>Connector</td><td>Digifit, BodyTrack and Wikilife</td><td>S</td><td>No</td></tr><tr><td>Web-based application</td><td></td><td>C</td><td>Yes</td></tr><tr><td colspan="4">Data visualisation</td></tr><tr><td>Web-based application</td><td>Digifit website, BodyTrack, and Wikilife</td><td>C</td><td>Yes</td></tr><tr><td>Data sharing</td><td></td><td></td><td></td></tr><tr><td>Application has a feature for sharing data with social networks such as Facebook</td><td>Digifit website, BodyTrack, and Wikilife</td><td>C</td><td>Yes</td></tr><tr><td>Application has a feature for importing data</td><td></td><td>C</td><td>Yes</td></tr></table> |
402be53c61f59c1ccd174aa8530654e1c20a9be912cdfb01d8589ab8db3877fb.png | complex | <table><tr><td rowspan="2"></td><td>Overall</td><td colspan="4">GFR category<sup>a</sup></td></tr><tr><td></td><td>G1</td><td>G2</td><td>G3a</td><td>G3b-G5</td></tr><tr><td>MDRD vs. CKD-EPIcrecys</td><td>16.7 (15.9%)</td><td>17.5 (15.1%)</td><td>16.1 (18.3%)</td><td>6.4 (11.1%)</td><td>2.2 (6.0%)</td></tr><tr><td>MDRD vs. CKD-EPIcre</td><td>6.8 (7.1%)</td><td>7.1 (6.6%)</td><td>6.9 (8.4%)</td><td>1.7 (3.1%)</td><td>0.3 (0.8%)</td></tr><tr><td>MDRD vs. CKD-EPIcys</td><td>22.9 (20.6%)</td><td>24.3 (20.4%)</td><td>20.0 (22.2%)</td><td>4.6 (8.2%)</td><td>3.5 (9.1%)</td></tr><tr><td>MDRD vs. LM</td><td>4.7 (5.6%)</td><td>9.6 (9.9%)</td><td>1.5 (1.9%)</td><td>1.4 (2.6%)</td><td>2.6 (7.7%)</td></tr><tr><td>MDRD vs. FAScre</td><td>3.3 (3.6%)</td><td>5.1 (4.7%)</td><td>2.0 (2.5%)</td><td>2.9 (5.5%)</td><td>0.1 (0.1%)</td></tr><tr><td>CKD-EPIcrecys vs. CKD-EPIcre</td><td>9.9 (10.4%)</td><td>10.1 (9.8%)</td><td>9.8 (13.2%)</td><td>5.4 (10.6%)</td><td>1.9 (5.4%)</td></tr><tr><td>CKD-EPIcrecys vs. CKD-EPIcys</td><td>6.2 (5.6%)</td><td>6.6 (5.7%)</td><td>4.3 (5.3%)</td><td>1.1 (2.0%)</td><td>0.8 (2.3%)</td></tr><tr><td>CKD-EPIcrecys vs. LM</td><td>21.4 (25.6%)</td><td>24.0 (26.1%)</td><td>17.6 (24.8%)</td><td>8.3 (16.6%)</td><td>4.8 (14.9%)</td></tr><tr><td>CKD-EPIcrecys vs. FAScre</td><td>13.4 (14.6%)</td><td>12.6 (12.3%)</td><td>16.2 (22.8%)</td><td>9.4 (19.0%)</td><td>2.0 (5.6%)</td></tr><tr><td>CKD-EPIcre vs. CKD-EPIcys</td><td>16.1 (14.5%)</td><td>16.8 (14.2%)</td><td>14.6 (16.8%)</td><td>3.5 (6.2%)</td><td>3.4 (9.0%)</td></tr><tr><td>CKD-EPIcre vs. LM</td><td>11.5 (13.7%)</td><td>15.0 (15.8%)</td><td>8.2 (11.0%)</td><td>3.3 (6.3%)</td><td>2.9 (8.9%)</td></tr><tr><td>CKD-EPIcre vs. FAScre</td><td>3.5 (3.8%)</td><td>2.2 (2.1%)</td><td>5.6 (7.4%)</td><td>4.6 (8.9%)</td><td>0.4 (1.1%)</td></tr><tr><td>CKD-EPIcys vs. LM</td><td>27.6 (33.0%)</td><td>30.1 (33.5%)</td><td>22.1 (32.2%)</td><td>7.0 (13.9%)</td><td>6.1 (18.7%)</td></tr><tr><td>CKD-EPIcys vs. FAScre</td><td>19.7 (21.4%)</td><td>19.4 (19.4%)</td><td>22.3 (32.7%)</td><td>8.0 (16.0%)</td><td>3.0 (8.7%)</td></tr><tr><td>LM vs. FAScre</td><td>8.0 (8.7%)</td><td>13.5 (12.4%)</td><td>3.5 (4.4%)</td><td>1.2 (2.3%)</td><td>2.1 (5.7%)</td></tr></table> |
da5955e8f699351f114594074cc49f328c8e29763afd2519af4e541b475744cb.png | complex | <table><tr><td rowspan="2">Pneumococcal serotype</td><td rowspan="2">Twofold response to vaccination</td><td colspan="3">Post-vaccination anti-CP<sup>†</sup> antibody concentration</td></tr><tr><td>≥0.35 μg/mL</td><td>≥1.00 μg/mL</td><td>≥5.00 μg/mL</td></tr><tr><td>6B (n = 10)</td><td>8</td><td>7</td><td>3</td><td>1</td></tr><tr><td>9V (n = 7)</td><td>5</td><td>7</td><td>5</td><td>2</td></tr><tr><td>19A (n = 1)</td><td>0</td><td>1</td><td>1</td><td>0</td></tr><tr><td>19F (n = 6)</td><td>5</td><td>5</td><td>3</td><td>2</td></tr><tr><td>23F (n = 7)</td><td>6</td><td>6</td><td>3</td><td>1</td></tr></table> |
227e873dde5ab40f2f8d59ae3ba91686e7af31c11ead3e62e80ac81b5c03cf10.png | simple | <table><tr><td>Probe ID</td><td>Symbol</td><td>Hazard Ratio</td><td>β</td><td><i>P</i> value</td><td>AUC</td></tr><tr><td>A_24_P21161</td><td>GPR85</td><td>0.368</td><td>−1.000</td><td>1.16E-05</td><td>0.7188</td></tr><tr><td>A_23_P215687</td><td>GPR85</td><td>0.135</td><td>−2.002</td><td>1.55E-05</td><td>0.8244</td></tr><tr><td>A_24_P300021</td><td>SHOX2</td><td>3.151</td><td>1.148</td><td>2.00E-05</td><td>0.8846</td></tr><tr><td>A_23_P134684</td><td>HMBOX1</td><td>0.103</td><td>−2.273</td><td>5.18E-05</td><td>0.9382<sup>a</sup></td></tr><tr><td>A_24_P102293</td><td>SLITRK5</td><td>0.552</td><td>−0.594</td><td>5.44E-05</td><td>0.9182</td></tr><tr><td>A_23_P210323</td><td>CEP68</td><td>0.149</td><td>−1.904</td><td>5.87E-05</td><td>0.9239</td></tr><tr><td>A_24_P417526</td><td>FRG1B</td><td>0.217</td><td>−1.528</td><td>7.51E-05</td><td>0.9346</td></tr><tr><td>A_23_P138574</td><td>ATE1</td><td>0.112</td><td>−2.189</td><td>7.83E-05</td><td>0.9379</td></tr><tr><td>A_23_P3602</td><td>NUDT7</td><td>0.348</td><td>−1.056</td><td>9.58E-05</td><td>0.9290</td></tr><tr><td>A_24_P167984</td><td>ATMIN</td><td>0.052</td><td>−2.957</td><td>0.0001195</td><td>0.9274</td></tr></table> |
7fc7528f40e027002a80d361954eca7c9b24a11dea65e587e8b0fdb0c8495abb.png | complex | <table><tr><td></td><td colspan="3">Free-ranging</td><td colspan="3">Captive</td></tr><tr><td></td><td><i>N</i>*</td><td>Mean ± SD</td><td>Median (25th, 75th percentiles)</td><td><i>N</i></td><td>mean ± SD</td><td>Median (25th, 75th percentiles)</td></tr><tr><td>NDF</td><td>8</td><td>63.6 ± 6.5</td><td>67.0 (56.7,68.0)<sup>A</sup></td><td>12</td><td>51.8 ± 5.9</td><td>51.2 (48.3,53.0)<sup>B</sup></td></tr><tr><td>ADF</td><td>8</td><td>43.0 ± 4.4<sup>a</sup></td><td>43.0 (40.0,46.7)</td><td>8</td><td>36.9 ± 6.1<sup>b</sup></td><td>37.9 (31.5,41.2)</td></tr><tr><td>ADL</td><td>8</td><td>35.2 ± 6.7</td><td>37.7 (31.8,39.4)<sup>A</sup></td><td>8</td><td>25.1 ± 5.0</td><td>23.7 (23.0,25.3)<sup>B</sup></td></tr><tr><td>TFN</td><td>8</td><td>4.3 ± 0.2<sup>a</sup></td><td>4.3 (4.1,4.4)</td><td>12</td><td>3.7 ± 0.6<sup>b</sup></td><td>3.9 (3.0,4.2)</td></tr><tr><td>NDF-N</td><td>8</td><td>3.2 ± 0.3<sup>a</sup></td><td>3.2 (2.9,3.5)</td><td>8</td><td>1.2 ± 0.7<sup>b</sup></td><td>0.9 (0.7,1.9)</td></tr><tr><td>MFN</td><td>8</td><td>1.1 ± 0.5</td><td>0.9 (0.7,1.6)<sup>A</sup></td><td>8</td><td>2.4 ± 0.7</td><td>2.1 (2.0,2.4)<sup>B</sup></td></tr><tr><td>TA</td><td>8</td><td>9.3 ± 2.0<sup>a</sup></td><td>8.8 (7.6,10.6)</td><td>12</td><td>13.9 ± 4.1<sup>b</sup></td><td>13.6 (10.4,15.8)</td></tr><tr><td>AIA</td><td>8</td><td>1.1 ± 1.1</td><td>0.7 (0.2,1.8)<sup>A</sup></td><td>8</td><td>2.8 ± 4.0</td><td>1.2 (0.4,3.4)<sup>B</sup></td></tr></table> |
f3a6f921fbe601f02d3cb38823b9b23388e9dbcd85267d855c4b93cb8b24e9a6.png | complex | <table><tr><td>Time segment in s</td><td colspan="2">Probe 1</td><td colspan="2">Probe 2</td><td colspan="2">Probe 3</td><td colspan="2">Probe 4</td></tr><tr><td></td><td><i>M</i></td><td>SE</td><td><i>M</i></td><td>SE</td><td><i>M</i></td><td>SE</td><td><i>M</i></td><td>SE</td></tr><tr><td colspan="9">CONTROL GROUP</td></tr><tr><td>5</td><td>0.028</td><td>0.022</td><td>0.079</td><td>0.044</td><td>0.071</td><td>0.041</td><td>0.032</td><td>0.020</td></tr><tr><td>10</td><td>0.144</td><td>0.039</td><td>0.164</td><td>0.052</td><td>0.134</td><td>0.052</td><td>0.098</td><td>0.048</td></tr><tr><td>15</td><td>0.134</td><td>0.041</td><td>0.26</td><td>0.07</td><td>0.142</td><td>0.052</td><td>0.135</td><td>0.049</td></tr><tr><td>20</td><td>0.201</td><td>0.051</td><td>0.381</td><td>0.082</td><td>0.179</td><td>0.059</td><td>0.214</td><td>0.068</td></tr><tr><td>25</td><td>0.322</td><td>0.078</td><td>0.519</td><td>0.084</td><td>0.343</td><td>0.079</td><td>0.332</td><td>0.058</td></tr><tr><td>30</td><td>0.505</td><td>0.081</td><td>0.702</td><td>0.066</td><td>0.642</td><td>0.072</td><td>0.75</td><td>0.068</td></tr><tr><td>35</td><td>0.668</td><td>0.056</td><td>0.774</td><td>0.066</td><td>0.809</td><td>0.07</td><td>0.886</td><td>0.047</td></tr><tr><td>40</td><td>0.724</td><td>0.064</td><td>0.727</td><td>0.069</td><td>0.905</td><td>0.044</td><td>0.892</td><td>0.055</td></tr><tr><td>45</td><td>0.719</td><td>0.063</td><td>0.726</td><td>0.066</td><td>0.921</td><td>0.037</td><td>0.914</td><td>0.046</td></tr><tr><td>50</td><td>0.74</td><td>0.062</td><td>0.708</td><td>0.076</td><td>0.828</td><td>0.07</td><td>0.873</td><td>0.053</td></tr><tr><td><i>M</i></td><td>0.419*</td><td>0.023</td><td>0.504</td><td>0.025</td><td>0.498</td><td>0.03</td><td>0.513</td><td>0.021</td></tr><tr><td colspan="9">DYSPHORIC GROUP</td></tr><tr><td>5</td><td>0.068</td><td>0.039</td><td>0.167</td><td>0.061</td><td>0.164</td><td>0.054</td><td>0.14</td><td>0.052</td></tr><tr><td>10</td><td>0.271</td><td>0.066</td><td>0.214</td><td>0.07</td><td>0.111</td><td>0.045</td><td>0.148</td><td>0.052</td></tr><tr><td>15</td><td>0.221</td><td>0.056</td><td>0.179</td><td>0.065</td><td>0.138</td><td>0.052</td><td>0.18</td><td>0.063</td></tr><tr><td>20</td><td>0.291</td><td>0.061</td><td>0.245</td><td>0.057</td><td>0.19</td><td>0.06</td><td>0.189</td><td>0.063</td></tr><tr><td>25</td><td>0.491</td><td>0.07</td><td>0.433</td><td>0.076</td><td>0.37</td><td>0.074</td><td>0.259</td><td>0.069</td></tr><tr><td>30</td><td>0.651</td><td>0.069</td><td>0.62</td><td>0.084</td><td>0.645</td><td>0.071</td><td>0.606</td><td>0.073</td></tr><tr><td>35</td><td>0.698</td><td>0.061</td><td>0.786</td><td>0.059</td><td>0.76</td><td>0.069</td><td>0.731</td><td>0.073</td></tr><tr><td>40</td><td>0.707</td><td>0.068</td><td>0.853</td><td>0.042</td><td>0.809</td><td>0.056</td><td>0.844</td><td>0.048</td></tr><tr><td>45</td><td>0.76</td><td>0.051</td><td>0.793</td><td>0.06</td><td>0.839</td><td>0.059</td><td>0.873</td><td>0.043</td></tr><tr><td>50</td><td>0.769</td><td>0.065</td><td>0.79</td><td>0.054</td><td>0.849</td><td>0.056</td><td>0.816</td><td>0.059</td></tr><tr><td><i>M</i></td><td>0.493*</td><td>0.020</td><td>0.508</td><td>0.021</td><td>0.488</td><td>0.026</td><td>0.479</td><td>0.022</td></tr></table> |
1ae70c02260ed68db434515b8d95bdb382e1459b2a2a5d172f094181d28b3880.png | simple | <table><tr><td>Species</td><td>Reads/Contigs</td><td>Number </td><td>Average size (nt)</td><td>Total nt</td></tr><tr><td><i>B. tuediae</i></td><td>Raw reads</td><td>547,061</td><td>547</td><td>299,232,484</td></tr><tr><td></td><td>Trimmed reads</td><td>546,903</td><td>333</td><td>182,128,133</td></tr><tr><td></td><td>All contigs</td><td>64,442</td><td>591</td><td>38,101,858</td></tr><tr><td></td><td>Large contigs</td><td>5072</td><td>1380</td><td>6,997,895</td></tr><tr><td></td><td>Single reads</td><td>118,104</td><td>279</td><td>33,008,862</td></tr><tr><td><i>H. digitata</i></td><td>Raw reads</td><td>546,974</td><td>543</td><td>296,833,666</td></tr><tr><td></td><td>Trimmed reads</td><td>546,846</td><td>331</td><td>181,169,361</td></tr><tr><td></td><td>All contigs</td><td>54,293</td><td>613</td><td>33,255,104</td></tr><tr><td></td><td>Large contigs</td><td>5083</td><td>1430</td><td>7,272,471</td></tr><tr><td></td><td>Single reads</td><td>105,695</td><td>260</td><td>27,786,964</td></tr></table> |
e54a97cb98b97db7fdc2a470e2330d6f9fb0c3a4d920f7d65e5df2646bcb3530.png | simple | <table><tr><td>Time seizure free after breakthrough seizure (months)</td><td>Number at risk</td><td>Risk of seizure in following 12 months. %</td></tr><tr><td>6</td><td>119</td><td>32 (28 to 36)</td></tr><tr><td>9</td><td>99</td><td>24 (21 to 27)</td></tr><tr><td>12</td><td>80</td><td>17 (15 to 19)</td></tr></table> |
65d55db0d472d06ef02f803dadb85d91856ff43fec9a8fa50fddf0d3f0b88475.png | complex | <table><tr><td></td><td>Variant</td><td>Total</td><td>CIN1</td><td>CIN2</td><td>CIN3</td><td>ICC</td><td>Adjusted OR<sup>a</sup>(95% CI)</td></tr><tr><td rowspan="6">HPV52</td><td>A1</td><td>2</td><td>0</td><td>0</td><td>2</td><td>0</td><td>-</td></tr><tr><td>A2</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>-</td></tr><tr><td>B1</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>-</td></tr><tr><td>B2</td><td>31</td><td>9</td><td>9</td><td>6</td><td>7</td><td>-</td></tr><tr><td>C</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>-</td></tr><tr><td>D</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>-</td></tr><tr><td rowspan="6">HPV58</td><td>A1</td><td>13</td><td>6</td><td>3</td><td>2</td><td>2</td><td>1.0 (reference)</td></tr><tr><td>A2</td><td>19</td><td>7</td><td>5</td><td>4</td><td>3</td><td>1.47 (0.35–6.17)</td></tr><tr><td>A3</td><td>3</td><td>1</td><td>0</td><td>1</td><td>1</td><td>1.71 (0.12–23.9)</td></tr><tr><td>B</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>ND</td></tr><tr><td>C</td><td>1</td><td>0</td><td>1</td><td>0</td><td>0</td><td>ND</td></tr><tr><td>D</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>ND</td></tr></table> |
bea3fc05414c6ad028bfcfa07112891ca7e38d45ccfc871683db56585e0cb51d.png | complex | <table><tr><td></td><td colspan="2">MZ twins</td><td colspan="2">DZ twins</td></tr><tr><td></td><td>Male</td><td>Female</td><td>Male</td><td>Female</td></tr><tr><td>Mean age</td><td>35.09 (15.27)</td><td>35.63 (15.20)</td><td>31.57 (13.98)</td><td>31.88 (13.45)</td></tr><tr><td>Mean HRS</td><td>5.85</td><td>5.5</td><td>6.08</td><td>5.79</td></tr><tr><td>Mean PADUA</td><td>6.99</td><td>6.7</td><td>7.04</td><td>6.99</td></tr><tr><td>Tics (prevalence)</td><td>192</td><td>188</td><td>175</td><td>162</td></tr></table> |
6d0573cf83318a44e80c8d1f456e380da490e92f0cb1aef7f4d44b01031dec49.png | complex | <table><tr><td colspan="2">Cardiac contractility dP/dt (mmHg/sec)</td></tr><tr><td>Control</td><td>SHR</td></tr><tr><td>1622 ± 120</td><td>1056 ± 182*</td></tr></table> |
f3fb42ec152c5e4ee9a229784b8617cb619b65a426222f9381455c0bf3dd14bf.png | simple | <table><tr><td>Corpus</td><td>Named entity types</td></tr><tr><td>GE</td><td>Protein</td></tr><tr><td>ID</td><td>Protein, chemical, organism, Regulon-operon,</td></tr><tr><td> </td><td>two-component-system</td></tr><tr><td>EPI</td><td>Protein</td></tr><tr><td>DNAm</td><td>Protein</td></tr><tr><td>EPTM</td><td>Protein</td></tr><tr><td>mTOR</td><td>Protein, Drug, ion, simple molecule, tag</td></tr><tr><td>MLEE</td><td>Protein, drug or compound, cellular component, cell, tissue,</td></tr><tr><td> </td><td>organ, anatomical system, organism, [ ...]</td></tr></table> |
7fb7d890077712bcca14e699e46eb8cd1ed3fe447d0ccd2dcee6687913d1419d.png | simple | <table><tr><td></td><td>Homeless</td><td>Housed</td></tr><tr><td>Cause of death</td><td>N (%)</td><td>N (%)</td></tr><tr><td> HIV/AIDS</td><td>156 (78%)</td><td>905 (83%)</td></tr><tr><td> Hepatitis</td><td>41 (21%)</td><td>130 (12%)</td></tr><tr><td> Liver disease</td><td>39 (20%)</td><td>160 (15%)</td></tr><tr><td> Septicemia</td><td>35 (18%)</td><td>121 (11%)</td></tr><tr><td> Mental illness</td><td>33 (17%)</td><td>52 (5%)</td></tr><tr><td> Heart disease</td><td>29 (15%)</td><td>201 (18%)</td></tr><tr><td> Pneumonia (non-AIDS-related)</td><td>27 (14%)</td><td>172 (16%)</td></tr><tr><td> Non-AIDS cancer</td><td>12 (6%)</td><td>139 (13%)</td></tr></table> |
197140f4a9a7c65f3aa00b70a07c018779b31ca188f6315392c996221ff13288.png | simple | <table><tr><td>Health Behaviour</td><td>Group</td><td>Net change%</td><td>Odds Ratio for change</td><td>95% CI</td><td>NNT#</td></tr><tr><td>Fish</td><td>Intervention</td><td>+7.06</td><td>1.37*</td><td>1.11-1.64</td><td>15</td></tr><tr><td> </td><td>Control</td><td>+0.84</td><td> </td><td> </td><td> </td></tr><tr><td>Spread</td><td>Intervention</td><td>+5.06</td><td>1.28*</td><td>1.06-1.51</td><td>21</td></tr><tr><td> </td><td>Control</td><td>+0.37</td><td> </td><td> </td><td> </td></tr><tr><td>Salt</td><td>Intervention</td><td>+5.43</td><td>1.19*</td><td>1.05-1.38</td><td>24</td></tr><tr><td> </td><td>Control</td><td>+1.23</td><td> </td><td> </td><td> </td></tr><tr><td>Veg and fruit</td><td>Intervention</td><td>+3.14</td><td>1.24</td><td>0.91-1.68</td><td>37</td></tr><tr><td> </td><td>Control</td><td>+0.49</td><td> </td><td> </td><td> </td></tr><tr><td>Meat</td><td>Intervention</td><td>+7.17</td><td>1.16</td><td>0.93-1.44</td><td>38</td></tr><tr><td> </td><td>Control</td><td>+4.48</td><td> </td><td> </td><td> </td></tr><tr><td>Milk</td><td>Intervention</td><td>+4.62</td><td>1.11</td><td>0.96-1.29</td><td>45</td></tr><tr><td> </td><td>Control</td><td>+1.80</td><td> </td><td> </td><td> </td></tr><tr><td>Alcohol</td><td>Intervention</td><td>+3.88</td><td>1.16</td><td>0.96-1.37</td><td>45</td></tr><tr><td> </td><td>Control</td><td>+1.12</td><td> </td><td> </td><td> </td></tr><tr><td>Physical activity</td><td>Intervention</td><td>+0.48</td><td>1.06</td><td>0.86-1.30</td><td>58</td></tr><tr><td> </td><td>Control</td><td>−1.34</td><td> </td><td> </td><td> </td></tr><tr><td>Body weight</td><td>Intervention</td><td>−0.12</td><td>0.96</td><td>0.85-1.09</td><td>161</td></tr><tr><td> </td><td>Control</td><td>−0.82</td><td> </td><td> </td><td> </td></tr><tr><td>Smoking</td><td>Intervention</td><td>+0.24</td><td>0.97</td><td>0.86-1.12</td><td>1000</td></tr><tr><td> </td><td>Control</td><td>+0.36</td><td> </td><td> </td><td> </td></tr></table> |
b21ccf8ed811c10e0014ede06ebf30917d2b203241806b88c23d9070405a09e0.png | complex | <table><tr><td> </td><td> </td><td colspan="3">Male</td><td colspan="3">Female</td></tr><tr><td> </td><td>Group</td><td>N</td><td>Mean</td><td>SD</td><td>N</td><td>Mean</td><td>SD</td></tr><tr><td rowspan="3">Permissiveness</td><td>Non-Koreans in US</td><td>79</td><td>3.34</td><td>.860</td><td>140</td><td>3.25</td><td>.884</td></tr><tr><td>Koreans in US</td><td>20</td><td>3.26</td><td>.909</td><td>24</td><td>3.76</td><td>.754</td></tr><tr><td>Koreans in Korea</td><td>30</td><td>3.78</td><td>.958</td><td>68</td><td>3.60</td><td>.774</td></tr><tr><td rowspan="3">Unpredictability</td><td>Non-Koreans in US</td><td>79</td><td>3.59</td><td>.683</td><td>140</td><td>3.56</td><td>.749</td></tr><tr><td>Koreans in US</td><td>20</td><td>3.43</td><td>.712</td><td>24</td><td>3.52</td><td>.801</td></tr><tr><td>Koreans in Korea</td><td>30</td><td>3.27</td><td>1.03</td><td>68</td><td>3.19</td><td>.707</td></tr><tr><td rowspan="3">Incomprehensibility</td><td>Non-Koreans in US</td><td>79</td><td>3.46</td><td>.674</td><td>140</td><td>3.55</td><td>.685</td></tr><tr><td>Koreans in US</td><td>20</td><td>3.31</td><td>.888</td><td>24</td><td>3.56</td><td>.650</td></tr><tr><td>Koreans in Korea</td><td>30</td><td>3.52</td><td>.741</td><td>68</td><td>3.49</td><td>.772</td></tr><tr><td rowspan="3">Noncommunication</td><td>Non-Koreans in US</td><td>79</td><td>2.59</td><td>.746</td><td>140</td><td>2.67</td><td>.704</td></tr><tr><td>Koreans in US</td><td>20</td><td>2.85</td><td>.829</td><td>24</td><td>2.85</td><td>.972</td></tr><tr><td>Koreans in Korea</td><td>30</td><td>2.62</td><td>.652</td><td>68</td><td>2.38</td><td>.697</td></tr><tr><td rowspan="3">Right to Prevent</td><td>Non-Koreans in US</td><td>79</td><td>2.27</td><td>.816</td><td>140</td><td>2.11</td><td>.784</td></tr><tr><td>Koreans in US</td><td>20</td><td>2.33</td><td>.878</td><td>24</td><td>1.71</td><td>.570</td></tr><tr><td>Koreans in Korea</td><td>30</td><td>1.75</td><td>.598</td><td>68</td><td>1.61</td><td>.510</td></tr><tr><td rowspan="3">Preventability</td><td>Non-Koreans in US</td><td>79</td><td>2.20</td><td>.745</td><td>140</td><td>2.33</td><td>.747</td></tr><tr><td>Koreans in US</td><td>20</td><td>1.85</td><td>.745</td><td>24</td><td>1.94</td><td>.712</td></tr><tr><td>Koreans in Korea</td><td>30</td><td>2.12</td><td>.715</td><td>68</td><td>2.14</td><td>.615</td></tr><tr><td rowspan="3">Relation-Caused</td><td>Non-Koreans in US</td><td>79</td><td>3.47</td><td>.769</td><td>140</td><td>3.53</td><td>.780</td></tr><tr><td>Koreans in US</td><td>20</td><td>3.70</td><td>.750</td><td>24</td><td>3.58</td><td>.670</td></tr><tr><td>Koreans in Korea</td><td>30</td><td>3.67</td><td>.802</td><td>68</td><td>3.26</td><td>.725</td></tr><tr><td rowspan="3">Duration of Suicidal Process</td><td>Non-Koreans in US</td><td>79</td><td>3.08</td><td>.544</td><td>140</td><td>3.06</td><td>.520</td></tr><tr><td>Koreans in US</td><td>20</td><td>2.82</td><td>.567</td><td>24</td><td>2.88</td><td>.535</td></tr><tr><td>Koreans in Korea</td><td>30</td><td>3.03</td><td>.596</td><td>68</td><td>3.16</td><td>.627</td></tr></table> |
8c42b0dea89d2cdc8f427e8056ea9b584b30e9ad39e6f193ee1b01c0c5e8e3ce.png | complex | <table><tr><td colspan="3">miRNAs repressing NF-κB signaling</td><td></td><td></td></tr><tr><td>miRNA</td><td>Gene</td><td>Transcripts</td><td>CS</td><td>CSP</td></tr><tr><td>miR-24</td><td>MYD88</td><td>NM_001172569, NM_002468, NM_001172568, NM_001172567, NM_001172566</td><td>-0.319</td><td>95</td></tr><tr><td></td><td>RASL11B</td><td>NM_023940</td><td>-0.35</td><td>96</td></tr><tr><td></td><td>RELA</td><td>NM_021975, NM_001145138</td><td>-0.307</td><td>93</td></tr><tr><td>miR-124</td><td>TRIM22</td><td>NM_001199573, NM_006074</td><td>-0.339</td><td>96</td></tr><tr><td></td><td>BECN1</td><td>NM_003766</td><td>-0.339</td><td>96</td></tr><tr><td>miR-210</td><td>CCNL2</td><td>NM_001039577</td><td>-0.275</td><td>85</td></tr><tr><td>miR-491</td><td>PLEKHB1</td><td>NM_021200, NM_001130033, NM_001130035, NM_001130034, NM_001130036</td><td>-0.314</td><td>98</td></tr><tr><td></td><td>TULP3</td><td>NM_003324</td><td>-0.278</td><td>97</td></tr><tr><td></td><td>TNFSF10</td><td>NM_001190943</td><td>-0.336</td><td>99</td></tr><tr><td>miR-506</td><td>RELA</td><td>NM_021975, NM_001145138</td><td>-0.401</td><td>98</td></tr><tr><td colspan="3">miRNAs activating NF-κB signaling</td><td></td><td></td></tr><tr><td>miRNA</td><td>Gene</td><td>Transcripts</td><td>CS</td><td>CSP</td></tr><tr><td></td><td>MATN2</td><td>NM_030583, NM_002380</td><td>-0.351</td><td>96</td></tr><tr><td>miR-30a</td><td>GPR161</td><td>NM_153832</td><td>-0.298</td><td>93</td></tr><tr><td></td><td>PTGER2</td><td>NM_000956</td><td>-0.328</td><td>95</td></tr><tr><td>miR-34b</td><td>TLR7</td><td>NM_016562</td><td>-0.356</td><td>98</td></tr><tr><td>miR-125b</td><td>IKBKG</td><td>NM_001099857, NM_001099856, NM_001145255</td><td>-0.297</td><td>92</td></tr><tr><td></td><td>MAP3K11</td><td>NM_002419</td><td>-0.337</td><td>95</td></tr><tr><td>miR-141</td><td>PTGDR</td><td>NM_000953</td><td>-0.3</td><td>97</td></tr><tr><td>miR-184</td><td>TNK2</td><td>NM_001010938, NM_005781</td><td>-0.452</td><td>94</td></tr><tr><td></td><td>SLC7A5</td><td>NM_003486</td><td>-0.306</td><td>85</td></tr><tr><td>miR-452*</td><td>LPAR2</td><td>NM_004720</td><td>-0.304</td><td>95</td></tr><tr><td></td><td>STMN1</td><td>NM_001145454</td><td>-0.367</td><td>98</td></tr><tr><td></td><td>NFKBIE</td><td>NM_004556</td><td>-0.288</td><td>94</td></tr><tr><td>miR-544</td><td>TSPAN13</td><td>NM_014399</td><td>-0.279</td><td>92</td></tr></table> |
bd7e49dca1ae04f115a917b313d1d531db905d966eceee556818aaf26ada7f4d.png | simple | <table><tr><td>No</td><td>Compound name</td><td>Area (%)</td><td>No</td><td>Compound name</td><td>Area (%)</td></tr><tr><td>1</td><td>3-Methyl butanol</td><td>0.14</td><td>19</td><td>β-Phellandrene</td><td>0.34</td></tr><tr><td>2</td><td>Eugenol</td><td>1.33</td><td>20</td><td>α -Thujene</td><td>1.26</td></tr><tr><td>3</td><td>1,8-Cineole</td><td>0.24</td><td>21</td><td>β -Caryophyllene</td><td>0.7</td></tr><tr><td>4</td><td>α -Pinene</td><td>0.99</td><td>22</td><td>γ-Terpinene</td><td>2.77</td></tr><tr><td>5</td><td>Geranyl acetone</td><td>0.5</td><td>23</td><td>Camphene</td><td>0.14</td></tr><tr><td>6</td><td>cis-Sabinene hydrate</td><td>0.68</td><td>24</td><td>α-Franesene</td><td>0.7</td></tr><tr><td>7</td><td>iso-Amylpropionate</td><td>0.23</td><td>25</td><td>Terpinolene</td><td>0.22</td></tr><tr><td>8</td><td>β-Bisabolene</td><td>3.77</td><td>26</td><td>β-Pinene</td><td>0.32</td></tr><tr><td>9</td><td>Linalool</td><td>3.32</td><td>27</td><td>α-Bisabolene</td><td>0.51</td></tr><tr><td>10</td><td>Myrcene</td><td>2.43</td><td>28</td><td>Nonanal</td><td>0.24</td></tr><tr><td>11</td><td>Caryophyllene oxide</td><td>1.53</td><td>29</td><td>trans-2-Carene-4-ol</td><td>0.73</td></tr><tr><td>12</td><td>4-Terpineol</td><td>4.1</td><td>30</td><td>β-Udesmol</td><td>0.32</td></tr><tr><td>13</td><td>iso-Butyl-2-methyl butyrate</td><td>0.19</td><td>31</td><td>α-Terpineol</td><td>0.42</td></tr><tr><td>14</td><td>Heptadecane</td><td>0.19</td><td>32</td><td>3-Carene</td><td>0.36</td></tr><tr><td>15</td><td>Thymyl methyl ether</td><td>1.21</td><td>33</td><td>α-Bisabolol</td><td>0.27</td></tr><tr><td>16</td><td>α-Terpinene</td><td>0.73</td><td>34</td><td>trans-Dihydrocarvone</td><td>0.26</td></tr><tr><td>17</td><td>Musk ambrette</td><td>0.08</td><td>35</td><td>para-Cymene</td><td>5.61</td></tr><tr><td>18</td><td>Carvacrol</td><td>63.17</td><td></td><td></td><td></td></tr></table> |
f7fd38a3d19a91cd02e2b9eb7953afaea2d3e47e9c30f12470b3407efe93d023.png | complex | <table><tr><td colspan="2">Demographic variables</td><td>N</td><td>%</td></tr><tr><td>Gender</td><td>Males</td><td>409</td><td>55.5</td></tr><tr><td> </td><td>Females</td><td>328</td><td>44.5</td></tr><tr><td>Year</td><td>First</td><td>149</td><td>20.2</td></tr><tr><td> </td><td>Second</td><td>183</td><td>24.8</td></tr><tr><td> </td><td>Third</td><td>152</td><td>20.6</td></tr><tr><td> </td><td>Fourth</td><td>143</td><td>19.4</td></tr><tr><td> </td><td>Fifth</td><td>69</td><td>9.3</td></tr><tr><td> </td><td>Sixth</td><td>41</td><td>5.6</td></tr></table> |
c0da054f001c4c07d9cd8bc9be0ce9b0b1882a002379d9930a5507f3d35aca6f.png | complex | <table><tr><td> </td><td colspan="3">BALP (U/L)</td><td colspan="3">Dpd (nmol/L)</td></tr><tr><td> </td><td>Control</td><td>CDNR</td><td><i>P</i> value</td><td>Control</td><td>CDNR</td><td><i>P</i> value</td></tr><tr><td>Day −1</td><td>3.582 ± 1.207</td><td>3.473 ± 1.391</td><td>0.882</td><td>3.665 ± 1.421</td><td>2.862 ± 0.577</td><td>0.229</td></tr><tr><td>Day 14</td><td>4.887 ± 1.610</td><td>4.606 ± 1.649</td><td>0.762</td><td>2.964 ± 1.118</td><td>2.614 ± 0.710</td><td>0.532</td></tr><tr><td>Day 28</td><td>5.909 ± 2.235</td><td>5.120 ± 2.458</td><td>0.557</td><td>2.761 ± 1.657</td><td>2.303 ± 0.624</td><td>0.540</td></tr><tr><td>Day 42</td><td>4.991 ± 1.605</td><td>5.283 ± 2.153</td><td>0.785</td><td>2.791 ± 1.586</td><td>1.891 ± 0.411</td><td>0.208</td></tr></table> |
5ec7cdc42b9d5212053ba540a3ab1bc3efd4c34373d173eeb8d82bd28c258753.png | simple | <table><tr><td> </td><td>UP1</td><td>UP2</td><td>UPps</td><td>SO1</td><td>SO2</td></tr><tr><td>Number of analysed branches</td><td>1,257</td><td>14,326</td><td>1,298</td><td>1,807</td><td>13,374</td></tr><tr><td>Branches with ω < 1 (%)<sup>a</sup></td><td>1,144 (91.01)</td><td>12,515 (87.36)</td><td>993 (76.50)</td><td>1,799 (99.56)</td><td>13,329 (99.66)</td></tr><tr><td>Mean ω for branches with ω < 1</td><td>0.41</td><td>0.49</td><td>0.59</td><td>0.28</td><td>0.29</td></tr><tr><td>Branches with ω > 1 (%)<sup>a</sup></td><td>113 (8.99)</td><td>1,811 (12.64)</td><td>305 (23.50)</td><td>8 (0.44)</td><td>45 (0.34)</td></tr><tr><td>Mean ω for branches with ω > 1</td><td>1.55</td><td>1.52</td><td>1.67</td><td>1.37</td><td>1.44</td></tr><tr><td>Branches with ω > 1.2 (%)<sup>a</sup></td><td>73 (5.81)</td><td>1,099 (8.78)</td><td>205 (15.79)</td><td>4 (0.22)</td><td>23 (0.17)</td></tr><tr><td>Mean ω for branches with ω > 1.2</td><td>1.81</td><td>1.80</td><td>1.95</td><td>1.64</td><td>1.79</td></tr><tr><td>Mean ω ± SE</td><td>0.51 ± 0.44</td><td>0.62 ± 0.47</td><td>0.84 ± 0.65</td><td>0.28 ± 0.17</td><td>0.29 ± 0.17</td></tr></table> |
d7ec06af1af13dd241ae8cdd48c6523de18bd1b88d6fa45553a9c3496a2fa206.png | simple | <table><tr><td> </td><td>Probe</td><td>Primer 1</td><td>Primer 2</td></tr><tr><td>APOA1</td><td>CTGCCAGAAATGCCGAGCCTG</td><td>CTTTGAGCACATCCACGTACA</td><td>GCCGTGCTCTTCCTGAC</td></tr><tr><td>APOB</td><td>CTGGATACCGTGTATGGAAACTGCTCC</td><td>CATTGCCCTTCCTCGTCTT</td><td>CCAGAGACAGAAGAAGCCAAG</td></tr><tr><td>CPS1</td><td>TCCAGCAATCATTCCGGCCAAGA</td><td>CCACAGGATTTAAGATACCCCAG</td><td>GTAATTGTTCAGCCACACCAAG</td></tr><tr><td>CYP1A1</td><td>TCTGTGATGTCCCGGATGTGGC</td><td>CCCAACCCTTCCCTGAATG</td><td>TTCTTCTCCTGACAGTGCTCAATC</td></tr><tr><td>FGA</td><td>CAGGCAGACGATCCTCATGGAAAACA</td><td>CAGCCCCACCCTTAGAAAAG</td><td>CTCCTTCAGCTAGAAAGTCACC</td></tr><tr><td>FGG</td><td>AATAAGGGAGCTAAACAGAGCGGGC</td><td>CAAAGACACGGTGCAAATCC</td><td>TTCCAGACCCATCGATTTCAC</td></tr><tr><td>GSTA1</td><td>CGGGCTGACATTCATCTGGTGGA</td><td>AAATCGCTACTTCCCTGCC</td><td>GGAAGCTGGAGATAAGACTGG</td></tr><tr><td>HGD</td><td>ATGCAGGCCACTCACAAAGTCTACTT</td><td>AGCAAGCCATTGTTAGACTT</td><td>CCTGATCCTAACCAGCTTAGATG</td></tr><tr><td>HNF1A</td><td>CAGGTTGGTGGTGTCGGTGATGA</td><td>GCCCTCTACAGCCACAAG</td><td>CAGTGTCTGAGGTGAAGACC</td></tr><tr><td>HNF4A</td><td>CAAGAAATGCTTCCGGGCTGGC</td><td>ATAGCTTGACCTTCGAGTGC</td><td>TGGACAAAGACAAGAGGAACC</td></tr><tr><td>LXR</td><td>TGCATAGCTCGTTCCCCAGCATTT</td><td>CCCTTCAGAACCCACAGAG</td><td>CGCAGCTCAGAACATTGTAGT</td></tr><tr><td>RPL13A</td><td>AGCAGTACCTGTTTAGCCACGATGG</td><td>GCCTTCACAGCGTACGA</td><td>CGAAGATGGCGGAGGTG</td></tr><tr><td>RXR</td><td>AGTACTGCCGCTACCAGAAGTGC</td><td>AGGACTGCCTGATTGACAAG</td><td>GACTCCACCTCATTCTCGTTC</td></tr><tr><td>SERPINA1</td><td>TGGTGCCTGAAGCTGAGGAGAC</td><td>AGCCAGGGAGACAGGGA</td><td>CTTAAATACGGACGAGGACAGG</td></tr><tr><td>SLC10A1</td><td>AACCTCAGCATTGTGATGACCACCT</td><td>TGTACAGGAGGAGAGGCATC</td><td>ACCTGTCCAATGTCTTCAGTC</td></tr><tr><td>TF</td><td>CTGTGTCAACTGTGTCCAGGGTGT</td><td>TGAGCCACGTAAACCTCTTG</td><td>AGTATTGGTTAAGGGTGGAGC</td></tr><tr><td>TTR</td><td>AGCAGCCTAGCTCAGGAGAAGTGA</td><td>CAGGTTTGCAGTCAGATTGG</td><td>CCATCCTGCCAAGAATGAGT</td></tr></table> |
7fb2dc8e5b89fead91ca3244610e129730c054610a9318dd6ba0527b99b98673.png | complex | <table><tr><td rowspan="3">Comorbid condition</td><td>Patients</td><td colspan="3">Age group [years]</td><td colspan="2">Gender [%]</td></tr><tr><td> </td><td><40</td><td>40–59</td><td>≥60</td><td>Male</td><td>Female</td></tr><tr><td><i>N</i> (%)</td><td><i>n</i> (%)</td><td><i>n</i> (%)</td><td><i>n</i> (%)</td><td><i>n</i> (%)</td><td><i>n</i> (%)</td></tr><tr><td>Coronary heart disease</td><td>202</td><td>7 (3.5)</td><td>71 (35.1)</td><td>124 (61.4)</td><td>66 (32.7)</td><td>136 (67.3)</td></tr><tr><td>Cerebrovascular disease</td><td>99</td><td>—</td><td>21 (21.2)</td><td>78 (78.8)</td><td>26 (26.3)</td><td>73 (73.7)</td></tr><tr><td>Diabetes mellitus</td><td>174</td><td>9 (5.2)</td><td>54 (31.0)</td><td>111 (63.8)</td><td>66 (27.9)</td><td>108 (62.1)</td></tr><tr><td>Cancer</td><td>351</td><td>19 (5.4)</td><td>162 (46.2)</td><td>170 (48.4)</td><td>81 (23.1)</td><td>270 (76.9)</td></tr><tr><td>Congestive heart failure</td><td>113</td><td>1 (0.9)</td><td>12 (10.6)</td><td>100 (88.5)</td><td>23 (20.4)</td><td>90 (79.6)</td></tr><tr><td>Chronic obstructive pulmonary disease</td><td>68</td><td>8 (11.8)</td><td>25 (36.5)</td><td>35 (51.5)</td><td>19 (27.9)</td><td>49 (72.1)</td></tr><tr><td>Comorbidities</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>0</td><td>1736</td><td>614 (35.4)</td><td>921 (53.1)</td><td>201 (11.6)</td><td>358 (20.6)</td><td>1378 (79.4)</td></tr><tr><td>1</td><td>504</td><td>40 (7.9)</td><td>257 (51.0)</td><td>207 (41.1)</td><td>142 (28.2)</td><td>362 (71.8)</td></tr><tr><td>≥2</td><td>204</td><td>2 (1.0)</td><td>40 (19.6)</td><td>162 (79.4)</td><td>55 (27.0)</td><td>149 (73.0)</td></tr><tr><td>Total</td><td>2444</td><td>656 (26.8)</td><td>1218 (49.8)</td><td>570 (23.3)</td><td>555 (22.7)</td><td>1889 (77.3)</td></tr></table> |
d49b4e3bb387ce2d4d4ed0bcc4e8433b0f746811daddaea5f27730aeb4d1f89a.png | simple | <table><tr><td></td><td>SVR (<i>n</i> = 251)</td><td>Response failure (<i>n</i> = 105)</td><td><i>P</i> values</td></tr><tr><td>Gender (males%)</td><td>145 (57.8)</td><td>52 (49.5)</td><td> 0.154</td></tr><tr><td>Age ≥ 40 years (<i>n</i>%)</td><td>123 (49.60)</td><td>80 (77.7)</td><td><0.001</td></tr><tr><td>IVDU (<i>n</i>%)</td><td>95 (37.8)</td><td>16 (15.4)</td><td><0.001</td></tr><tr><td>Alcohol abuse (<i>n</i>%)</td><td>27 (11.2)</td><td>14 (14.1)</td><td> 0.442</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>23.1 ± 3.8</td><td>24.6 ± 4.5</td><td> 0.035</td></tr><tr><td>Overweight (<i>n</i>%)</td><td>24 (28.6)</td><td>25 (50.0)</td><td> 0.013</td></tr><tr><td>Genotype distribution</td><td></td><td></td><td><0.001</td></tr><tr><td> Genotype 1</td><td>111 (45.5)</td><td>53 (52.5)</td><td></td></tr><tr><td> Genotype 2</td><td>17 (7.0)</td><td>6 (5.9)</td><td></td></tr><tr><td> Genotype 3</td><td>98 (40.2)</td><td>15 (14.9)</td><td></td></tr><tr><td> Genotype 4</td><td>18 (7.4)</td><td>27 (26.7)</td><td></td></tr><tr><td>High viral load (<i>n</i>%)</td><td>39 (40.6)</td><td>28 (45.8)</td><td> 0.515</td></tr><tr><td>Abnormal ALT (<i>n</i>%)</td><td>236 (96.7)</td><td>95 (95.0)</td><td> 0.447</td></tr><tr><td>Abnormal AST (<i>n</i>%)</td><td>199 (86.1)</td><td>77 (86.5)</td><td> 0.931</td></tr><tr><td>Hepatic steatosis (<i>n</i>%)</td><td>64 (25.7)</td><td>49 (46.7)</td><td><0.001</td></tr><tr><td>Severe inflammation (<i>n</i>%)</td><td>9 (3.8)</td><td>8 (8.5)</td><td> 0.080</td></tr><tr><td>Advanced fibrosis (<i>n</i>%)</td><td>26 (10,5)</td><td>30 (28,6)</td><td><0.001</td></tr><tr><td>Cirrhosis (<i>n</i>%)</td><td>7 (2,8)</td><td>14 (13,3)</td><td><0.001</td></tr><tr><td>Type of IFN</td><td></td><td></td><td> 0.987</td></tr><tr><td> PegIFN<i>α</i>-2a (<i>n</i>%)</td><td>69 (28.6)</td><td>27 (28.7)</td><td></td></tr><tr><td> PegIFN<i>α</i>-2b (<i>n</i>%)</td><td>172 (71.4)</td><td>67 (71.3)</td><td></td></tr><tr><td>Dosage adherence (<i>n</i>%)</td><td>173 (80.8)</td><td>60 (82.2)</td><td> 0.799</td></tr></table> |
74f2b3de868d229be3b97e93bb6729a33082e49b77f8d8f399a5b8a9d339c471.png | simple | <table><tr><td>Covariates</td><td>OR</td><td>95% CI</td><td><i>P</i>-value</td></tr><tr><td>Unemployment (<i>n</i>=131)</td><td>0.97</td><td>0.24-3.77</td><td>0.961</td></tr><tr><td>Light physical activity (hours/week)(<i>n</i>=130)</td><td>1.00</td><td>0.93-1.08</td><td>0.947</td></tr><tr><td>Moderate physical activity (hours/week)(<i>n</i>=130)</td><td>0.87</td><td>0.70-1.07</td><td>0.193</td></tr><tr><td>Vigorous physical activity (hours/week)(<i>n</i>=131)</td><td>0.91</td><td>0.66-1.26</td><td>0.588</td></tr><tr><td>MIDAS score (0-270)(<i>n</i>=131)</td><td>1.02</td><td>1.00-1.04</td><td>0.032</td></tr><tr><td>MIDAS-intensity (NRS 0-10) (<i>n</i>=131)</td><td>1.49</td><td>1.03-2.15</td><td>0.034</td></tr><tr><td>MIDAS-frequency (days last 3 months) (<i>n</i>=131)</td><td>1.02</td><td>1.00-1.04</td><td>0.032</td></tr><tr><td>Neuroticism score (12-60) (<i>n</i>=131)</td><td>1.06</td><td>0.99-1.13</td><td>0.069</td></tr><tr><td>Extraversion score (12-60) (<i>n</i>=131)</td><td>0.96</td><td>0.88-1.04</td><td>0.275</td></tr><tr><td>Openness score (12-60) (<i>n</i>=131)</td><td>0.99</td><td>0.91-1.08</td><td>0.763</td></tr><tr><td>Agreeableness score (12-60) (<i>n</i>=131)</td><td>1.00</td><td>0.93-1.08</td><td>0.970</td></tr><tr><td>Conscientiousness score (12-60) (<i>n</i>=131)</td><td>0.95</td><td>0.87-1.03</td><td>0.206</td></tr></table> |
f5d944707d3e0a64294eb06788662b09d8fcd7d2a35eebbed93c8b68ca3da2c8.png | complex | <table><tr><td>RT</td><td>Isolate name<sup><i>a</i></sup></td><td>RFLP type<sup><i>b</i></sup></td><td>IIIB-specific PCR<sup><i>c</i></sup></td><td colspan="5">Alleles at the following loci</td></tr><tr><td></td><td></td><td></td><td></td><td><i>recA</i></td><td><i>gyrB</i></td><td><i>fliC</i></td><td><i>cepIR</i></td><td><i>dsbA</i></td></tr><tr><td>Group 1</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> 74</td><td>MDII-143p</td><td>I</td><td>+</td><td>9</td><td>10</td><td>2</td><td>4</td><td>1</td></tr><tr><td> 112</td><td>MDII-151p</td><td>I</td><td>+</td><td>9</td><td>8</td><td>2</td><td>4</td><td>1</td></tr><tr><td>Group 2</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> 100</td><td>MDIII-B604</td><td>I</td><td>+</td><td>9</td><td>9</td><td>4</td><td>4</td><td>1</td></tr><tr><td> 17</td><td>MexII-968</td><td>I</td><td>+</td><td>9</td><td>9</td><td>1</td><td>4</td><td>1</td></tr><tr><td colspan="2">Group 3 (RT-4-complex)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> 115</td><td>MDIII-B752</td><td>J'</td><td>+</td><td>10</td><td>9</td><td>2</td><td>7</td><td>1</td></tr><tr><td> 21</td><td>MDIII-P378</td><td>J'</td><td>+</td><td>10</td><td>4</td><td>2</td><td>1</td><td>1</td></tr><tr><td> 21</td><td>MexII-864</td><td>J'</td><td>+</td><td>10</td><td>4</td><td>2</td><td>1</td><td>1</td></tr><tr><td> 3</td><td>MexII-57</td><td>J'</td><td>+</td><td>10</td><td>10</td><td>2</td><td>1</td><td>2</td></tr><tr><td> 7</td><td>MexII-60</td><td>J'</td><td>+</td><td>10</td><td>10</td><td>2</td><td>8</td><td>2</td></tr><tr><td> 7</td><td>MexII-857</td><td>J'</td><td>+</td><td>10</td><td>10</td><td>2</td><td>8</td><td>2</td></tr><tr><td> 6</td><td>MexII-815</td><td>J'</td><td>+</td><td>10</td><td>10</td><td>2</td><td>1</td><td>1</td></tr><tr><td> 53</td><td>MexII-845</td><td>J'</td><td>+</td><td>10</td><td>8</td><td>1</td><td>1</td><td>1</td></tr><tr><td> 31</td><td>MexII-940</td><td>J'</td><td>+</td><td>10</td><td>9</td><td>1</td><td>1</td><td>1</td></tr><tr><td> 36</td><td>MexII-945</td><td>J'</td><td>+</td><td>10</td><td>4</td><td>2</td><td>6</td><td>1</td></tr><tr><td> 4*</td><td>MexII-967</td><td>J'</td><td>+</td><td>10</td><td>9</td><td>2</td><td>1</td><td>1</td></tr><tr><td> 67</td><td>MexII-974</td><td>J'</td><td>+</td><td>10</td><td>8</td><td>2</td><td>6</td><td>1</td></tr><tr><td> 57</td><td>MexII-994</td><td>J'</td><td>+</td><td>10</td><td>8</td><td>2</td><td>1</td><td>2</td></tr><tr><td>Group 4</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> 50</td><td>MexII-867</td><td>uk<sup><i>d</i></sup></td><td>+</td><td>11</td><td>8</td><td>6</td><td>1</td><td>1</td></tr><tr><td> 46</td><td>MexII-976</td><td>I</td><td>+</td><td>9</td><td>8</td><td>6</td><td>1</td><td>1</td></tr><tr><td>Singletons</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> 80</td><td>MCII-168</td><td>J'</td><td>+</td><td>10</td><td>5</td><td>3</td><td>6</td><td>2</td></tr><tr><td> 27</td><td>MDII-129r</td><td>I</td><td>+</td><td>9</td><td>4</td><td>2</td><td>6</td><td>2</td></tr><tr><td> 75</td><td>MDIII-B250</td><td>J'</td><td>+</td><td>10</td><td>8</td><td>4</td><td>4</td><td>1</td></tr><tr><td> 114</td><td>MDIII-B716</td><td>I</td><td>+</td><td>9</td><td>4</td><td>2</td><td>7</td><td>1</td></tr><tr><td> 28</td><td>MDIII-P410</td><td>I</td><td>+</td><td>9</td><td>4</td><td>5</td><td>7</td><td>2</td></tr><tr><td> 22</td><td>MDIII-P461</td><td>J'</td><td>+</td><td>10</td><td>4</td><td>2</td><td>7</td><td>2</td></tr><tr><td> 29</td><td>MDIII-T228</td><td>I</td><td>+</td><td>9</td><td>4</td><td>4</td><td>1</td><td>1</td></tr><tr><td> 103</td><td>MDIII-T521</td><td>J'</td><td>+</td><td>10</td><td>9</td><td>4</td><td>4</td><td>2</td></tr><tr><td> 70</td><td>MexII-206</td><td>uk<sup><i>e</i></sup></td><td>+</td><td>13</td><td>10</td><td>5</td><td>7</td><td>2</td></tr><tr><td> 47</td><td>MexII-264</td><td>J'</td><td>+</td><td>10</td><td>2</td><td>1</td><td>2</td><td>2</td></tr><tr><td> 48</td><td>MexII-828</td><td>J'</td><td>+</td><td>10</td><td>2</td><td>2</td><td>4</td><td>1</td></tr><tr><td> 33</td><td>MexII-863</td><td>J'</td><td>+</td><td>10</td><td>4</td><td>6</td><td>10</td><td>2</td></tr></table> |
b67f4703dd532ac261b91361f99f3a3fa62a1060fcc37e7b7deb3ccc2d2ad351.png | simple | <table><tr><td>Pathological target</td><td>Putative mechanism</td><td>Examples of supporting references</td><td>Form of MS most likely to benefit</td></tr><tr><td>T- and B-cells</td><td>Limit cell proliferation in the periphery and possibly in the CNS</td><td>Lederman et al., 1984</td><td>RRMS</td></tr><tr><td></td><td></td><td>Warnke et al., 2009</td><td></td></tr><tr><td></td><td></td><td>Sweeney et al., 2011</td><td></td></tr><tr><td>Cytokines</td><td>Modulate cytokine production in the periphery and possibly in the CNS</td><td>Del Vecchio et al., 2002</td><td>RRMS</td></tr><tr><td></td><td></td><td>Weibach et al., 2004</td><td></td></tr><tr><td></td><td></td><td>Leung et al., 2005</td><td></td></tr><tr><td>Perivascular iron (heme) deposits</td><td>Limit iron catalyzed tissue damage to myelin, the BBB, etc.</td><td>Wu et al., 1993</td><td>RRMS</td></tr><tr><td></td><td></td><td>Guy et al., 1994</td><td></td></tr><tr><td></td><td></td><td>Nakamura et al., 2004</td><td></td></tr><tr><td></td><td>Stabilize HIF-1α</td><td>Schofield and Ratcliffe, 2005</td><td></td></tr><tr><td></td><td></td><td>Semenza, 2012</td><td></td></tr><tr><td></td><td></td><td>Singh et al., 2012</td><td></td></tr><tr><td>Demyelination and axonal injury leading to release of iron (or heme) containing products</td><td>Limit amplification of tissue damage by iron catalyzed reactions</td><td>Wu et al., 1993</td><td>RRMS/SPMS</td></tr><tr><td></td><td></td><td>Kadiiska et al., 1995</td><td></td></tr><tr><td></td><td></td><td>Nakamura et al., 2004</td><td></td></tr><tr><td></td><td></td><td>Merkofer et al., 2006</td><td></td></tr><tr><td></td><td>Stabilize HIF-1α</td><td>Schofield and Ratcliffe, 2005</td><td></td></tr><tr><td></td><td></td><td>Semenza, 2012</td><td></td></tr><tr><td></td><td></td><td>Singh et al., 2012</td><td></td></tr><tr><td>Activated and iron enriched macrophage, microglia or astrocytes</td><td>Limit production of ROS</td><td>Rajesh et al., 2004</td><td>RRMS/SPMS</td></tr><tr><td></td><td>Limit production of proinflammatory cytokines</td><td>Molina-Holgado et al., 2008</td><td></td></tr><tr><td></td><td></td><td>Rathnasamy et al., 2011, 2013</td><td></td></tr><tr><td></td><td>Limit production of MMP-9</td><td>Mairuae et al., 2011</td><td></td></tr><tr><td></td><td>Improve glutamate uptake to lower extracellular levels</td><td>Fernandes et al., 2011</td><td></td></tr><tr><td>Altered mitochondrial function in neurons</td><td>Limit ROS production by mitochondria</td><td>Richardson et al, 2001</td><td>RRMS/SPMS</td></tr><tr><td></td><td></td><td>Liang et al., 2008</td><td></td></tr><tr><td></td><td></td><td>Im et al., 2012</td><td></td></tr><tr><td></td><td>Limit caspase-3 activation by mitochondria</td><td>Zhang et al., 2009</td><td></td></tr><tr><td>Enhanced iron deposition in deep gray matter</td><td>Limit glutamate excitotoxicity</td><td>Papazisis et al., 2008</td><td>RRMS/SPMS</td></tr><tr><td></td><td></td><td>Yu et al., 2009</td><td></td></tr><tr><td></td><td>Protect against oxidative stress</td><td>Molina-Holgado et al., 2008</td><td></td></tr><tr><td></td><td>Reduce brain iron uptake</td><td>Crowe and Morgan, 1994</td><td></td></tr><tr><td></td><td>Lessen iron induced inhibition of DNA repair machinery</td><td>Li et al., 2009</td><td></td></tr><tr><td></td><td>Stabilize HIF-1α</td><td>Schofield and Ratcliffe, 2005</td><td></td></tr><tr><td></td><td></td><td>Semenza, 2012</td><td></td></tr><tr><td></td><td></td><td>Singh et al., 2012</td><td></td></tr></table> |
0de8fe7c6a5737c21ecef57669276528b1b84ccdce9c818f18af63061eb9ad93.png | complex | <table><tr><td>Anatomical location</td><td colspan="3">Talairach coordinates</td><td>Volume (mm<sup>3</sup>)</td></tr><tr><td></td><td><i>x</i></td><td><i>y</i></td><td><i>z</i></td><td></td></tr><tr><td colspan="5">VOCALIZATIONS > ACTION SOUNDS (<i>P</i> < 0.001)</td></tr><tr><td>Left aSTG</td><td>−58</td><td>−4</td><td>2</td><td>20,069</td></tr><tr><td>Left temporal pole</td><td>−34</td><td>10</td><td>−34</td><td>31</td></tr><tr><td>Right aSTG</td><td>54</td><td>−4</td><td>1</td><td>16,801</td></tr><tr><td>Right precentral g. (M1)</td><td>47</td><td>0</td><td>48</td><td>3303</td></tr><tr><td colspan="5">ACTIONS SOUNDS > VOCALIZATIONS (<i>P</i> < 0.001)</td></tr><tr><td>Left Posterior Insula</td><td>−36</td><td>−28</td><td>18</td><td>1216</td></tr><tr><td>Right Posterior Insula</td><td>32</td><td>−16</td><td>15</td><td>761</td></tr><tr><td colspan="5">ACTIONS SOUNDS > VOCALIZATIONS (<i>P</i> < 0.05)</td></tr><tr><td>Left MFG</td><td>−43</td><td>9</td><td>32</td><td>2848</td></tr><tr><td>Left Parietal</td><td>−42</td><td>−36</td><td>31</td><td>2011</td></tr><tr><td>Left pSTS</td><td>−52</td><td>−50</td><td>3</td><td>964</td></tr><tr><td>Left aIFS/vlPFC</td><td>−45</td><td>41</td><td>8</td><td>4908</td></tr><tr><td>Right aIFS/vlPFC</td><td>30</td><td>29</td><td>6</td><td>2836</td></tr></table> |
cafa098d9ef03d8ebbee38cfb3879dae5d510008f08ee3db4db4501b8edf846b.png | complex | <table><tr><td rowspan="2">Variable factors<sup><i>a</i></sup></td><td>Eye irritationOR (95% CI)</td><td>General symptomsOR (95% CI)</td><td>Upper respiratoryOR (95% CI)</td><td>Skin symptomsOR (95% CI)</td></tr><tr><td><i>N</i> = 2587</td><td><i>N</i> = 2502</td><td><i>N</i> = 2483</td><td><i>N</i> = 2684</td></tr><tr><td>Too much air movement</td><td>0.78 (0.55–1.09)</td><td>0.95 (0.69–1.32)</td><td>1.00 (0.66–1.53)</td><td>0.61 (0.31–1.23)</td></tr><tr><td>Too little air movement</td><td>1.00 (0.87–1.15)</td><td>1.31 (1.14–1.50)<sup>**</sup></td><td>1.23 (1.03–1.49)<sup>*</sup></td><td>1.13 (0.84–1.54)</td></tr><tr><td>Too hot</td><td>1.09 (0.94–1.26)</td><td>1.15 (1.00–1.33)</td><td>1.26 (1.03–1.54)<sup>*</sup></td><td>1.13 (0.80–1.60)</td></tr><tr><td>Varying room temperature</td><td>1.16 (0.98–1.36)</td><td>1.00 (0.85–1.18)</td><td>1.03 (0.82–1.29)</td><td>1.11 (0.77–1.60)</td></tr><tr><td>Too cold</td><td>0.97 (0.80–1.18)</td><td>1.38 (1.13–1.68)<sup>**</sup></td><td>1.12 (0.87–1.44)</td><td>0.91 (0.61–1.35)</td></tr><tr><td>Air too humid</td><td>1.21 (1.02–1.45) <sup>*</sup></td><td>1.12 (0.94–1.34)</td><td>0.89 (0.69–1.13)</td><td>0.98 (0.67–1.43)</td></tr><tr><td>Air too dry</td><td>1.49 (1.25–1.77)<sup>**</sup></td><td>1.23 (1.02–1.47)<sup>*</sup></td><td>1.78 (1.44–2.19)<sup>**</sup></td><td>2.56 (1.83–3.57)<sup>**</sup></td></tr><tr><td>Static electricity</td><td>1.38 (1.01–1.90)<sup>*</sup></td><td>1.08 (0.76–1.53)</td><td>0.68 (0.43–1.05)</td><td>1.10 (0.63–1.90)</td></tr><tr><td>Noise</td><td>1.23 (0.99–1.52)</td><td>1.50 (1.22–1.84)<sup>**</sup></td><td>1.34 (1.03–1.76) <sup>*</sup></td><td>1.22 (0.81–1.86)</td></tr><tr><td>Airflow from air conditioner</td><td>1.11 (0.96–1.28)</td><td>1.11 (0.96–1.28)</td><td>1.13 (0.93–1.36)</td><td>0.89 (0.64–1.25)</td></tr><tr><td>Odors from air conditioner</td><td>1.07 (0.83–1.39)</td><td>1.01 (0.77–1.32)</td><td>0.94 (0.67–1.31)</td><td>1.25 (0.75–2.09)</td></tr><tr><td>Mold odor</td><td>0.90 (0.66–1.24)</td><td>0.84 (0.61–1.16)</td><td>1.09 (0.75–1.58)</td><td>0.64 (0.35–1.17)</td></tr><tr><td>Dust and dirt</td><td>1.08 (0.88–1.32)</td><td>1.10 (0.90–1.34)</td><td>1.22 (0.96–1.55)</td><td>0.82 (0.55–1.22)</td></tr><tr><td>Tobacco smoke odor</td><td>1.22 (1.03–1.43)<sup>*</sup></td><td>1.23 (1.04–1.45) <sup>*</sup></td><td>1.19 (0.97–1.46)</td><td>1.23 (0.88–1.70)</td></tr><tr><td>Unpleasant chemical odor</td><td>1.03 (0.69–1.56)</td><td>0.87 (0.57–1.32)</td><td>1.56 (1.01–2.42) <sup>*</sup></td><td>2.52 (1.44–4.42)<sup>**</sup></td></tr><tr><td>Unpleasant other odor<sup><i>b</i></sup></td><td>1.19 (1.00–1.42)</td><td>1.37 (1.15–1.64)<sup>**</sup></td><td>1.20 (0.96–1.50)</td><td>1.55 (1.10–2.19)<sup>*</sup></td></tr></table> |
1fd1cb8eb8ca89f375846b96d297cb5c52d7769756923201024f5061ab0adf7f.png | complex | <table><tr><td rowspan="2">Treatment</td><td rowspan="2">Dose</td><td colspan="4">Analgesic response (mean time in seconds ± SEM)</td></tr><tr><td>30 min</td><td>60 min</td><td>90 min</td><td>120 min</td></tr><tr><td>Control (normal saline)</td><td>1.0 mL/kg</td><td>7.03 ± 0.44</td><td>7.34 ± 0.44</td><td>7.71 ± 0.25</td><td>7.32 ± 0.21</td></tr><tr><td>E5</td><td>1.0 mg/kg</td><td>17.66 ± 1.54</td><td>19.76 ± 0.26*</td><td>18.41 ± 0.47*</td><td>17.91 ± 0.45*</td></tr><tr><td>E3 </td><td>1.0 mg/kg</td><td>22.51 ± 2.01</td><td>25.36 ± 0.21*</td><td>25.66 ± 0.29*</td><td>21.05 ± 0.33*</td></tr><tr><td>Standard (Piroxicam suspension)</td><td>1.0 mg/kg</td><td>16.95 ± 0.26*</td><td>17.41 ± 0.37*</td><td>18.3 ± 0.84*</td><td>17.81 ± 1.79*</td></tr></table> |
7b54900bff11b717766c269b0637f9e92024ed2b18d81e040d73e9754bde0dde.png | simple | <table><tr><td></td><td><i>n</i></td><td>CD8<sup>+</sup></td><td>CD19<sup>+</sup></td><td>CD3<sup>+</sup></td><td>CD4<sup>+</sup></td><td>NK</td></tr><tr><td>Case group</td><td>715</td><td>29.3 ± 11.6*</td><td>3.0 ± 2.7*</td><td>69.3 ± 11.9</td><td>35.1 ± 10.2</td><td>15.1 ± 8.3*</td></tr><tr><td>Control group</td><td>100</td><td>24.7 ± 6.1</td><td>13.6 ± 3.9</td><td>69.6 ± 10.5</td><td>35.7 ± 7.3</td><td>17.0 ± 5.2</td></tr><tr><td><i>P</i> value</td><td></td><td>< 0.001</td><td>< 0.001</td><td>0.798</td><td>0.578</td><td>0.026</td></tr></table> |
09cffaf35e30d5cc69a1bbc32b932a35231bd693aa0a6d43ba9c277a49e4019d.png | complex | <table><tr><td>Gene with likely pathogenic variant</td><td colspan="3">Steroid-resistant nephrotic syndrome (number of patients)</td><td colspan="3">Haematuria/Alport syndrome (number of patients)</td></tr><tr><td>Age group*</td><td>≤18 years (n=209)</td><td>>18 years (n=46)</td><td>Total (n=255)</td><td>≤18 years (n=20)</td><td>>18 years (n=15)</td><td>Total (n=35)</td></tr><tr><td>NPHS1</td><td>12</td><td>0</td><td>12</td><td>0</td><td>0</td><td>0</td></tr><tr><td>WT1</td><td>9</td><td>2</td><td>11</td><td>0</td><td>0</td><td>0</td></tr><tr><td>NPHS2</td><td>7</td><td>0</td><td>7</td><td>0</td><td>0</td><td>0</td></tr><tr><td>LMX1B</td><td>4</td><td>0</td><td>4</td><td>0</td><td>0</td><td>0</td></tr><tr><td>INF2</td><td>0</td><td>3</td><td>3</td><td>0</td><td>0</td><td>0</td></tr><tr><td>LAMB2</td><td>3</td><td>0</td><td>3</td><td>0</td><td>0</td><td>0</td></tr><tr><td>MYH9</td><td>2</td><td>0</td><td>2</td><td>0</td><td>0</td><td>0</td></tr><tr><td>PLCE1</td><td>2</td><td>0</td><td>2</td><td>0</td><td>0</td><td>0</td></tr><tr><td>ACTN4</td><td>1</td><td>0</td><td>1</td><td>0</td><td>0</td><td>0</td></tr><tr><td>SCARB2</td><td>0</td><td>1</td><td>1</td><td>0</td><td>0</td><td>0</td></tr><tr><td>SMARCAL1</td><td>1</td><td>0</td><td>1</td><td>0</td><td>0</td><td>0</td></tr><tr><td>TRPC6</td><td>0</td><td>1</td><td>1</td><td>0</td><td>0</td><td>0</td></tr><tr><td>COL4A3</td><td>0</td><td>1</td><td>1</td><td>3</td><td>2</td><td>5</td></tr><tr><td>COL4A4</td><td>1</td><td>1†</td><td>2</td><td>0</td><td>2</td><td>2</td></tr><tr><td>COL4A5</td><td>2</td><td>1</td><td>3</td><td>5</td><td>5</td><td>10</td></tr><tr><td>Total</td><td>44</td><td>10</td><td>54</td><td>8</td><td>9</td><td>17</td></tr></table> |
51c18b7e79062d7949da19e495a632471f436396fa6131f4847309781c5129be.png | complex | <table><tr><td rowspan="3"></td><td rowspan="3"></td><td colspan="4">Predicted class</td></tr><tr><td>Cluster 1</td><td>Cluster 2</td><td>Cluster 3</td><td>Cluster 4</td></tr><tr><td rowspan="4">Actual class</td><td>Cluster 1</td><td>199</td><td>49</td><td>1</td><td>25</td></tr><tr><td>Cluster 2</td><td>5</td><td>441</td><td>2</td><td>0</td></tr><tr><td>Cluster 3</td><td>0</td><td>0</td><td>221</td><td>0</td></tr><tr><td>Cluster 4</td><td>0</td><td>0</td><td>0</td><td>312</td></tr></table> |
112ac9cdb436ee0d761bcac6f012422e52f416c3c269297ef11eafcc4ce22532.png | complex | <table><tr><td>Extracted Plant</td><td>Extracted Part</td><td>IC<sub>50</sub> (mg/mL)</td><td>Lead Substance</td><td>Content (μg/mg)</td><td colspan="2">IC<sub>50</sub></td></tr><tr><td><i>Arbutus unedo</i> (strawberry tree)</td><td>fruit</td><td>n.d. <sup>1</sup></td><td>arbutin</td><td>20.0 ± 1.3</td><td>n.d. <sup>1</sup></td><td>n.d. <sup>1</sup></td></tr><tr><td><i>Camellia sinensis</i> (tea)</td><td>dried leaves</td><td>n.d. <sup>1</sup></td><td>caffeine</td><td>131.6 ± 5.0</td><td>0.9 ± 0.1 mg/mL</td><td>4.8 ± 0.6 mM</td></tr><tr><td rowspan="5"><i>Cynara scolymus</i> (artichoke)</td><td rowspan="5">dried leaves</td><td rowspan="5">0.9 ± 0.1</td><td>3,4-diCQA</td><td>2.5 ± 0.5</td><td>>500 μg/mL (49%)</td><td>>1.0 mM</td></tr><tr><td>luteolin</td><td><0.08</td><td>11.8 ± 2.9 μg/mL</td><td>41 ± 10 μM</td></tr><tr><td>luteolin-7-<i>O</i>-glucuronide</td><td>2.7 ± 0.3</td><td>n.d. <sup>1</sup></td><td>n.d. <sup>1</sup></td></tr><tr><td>luteolin-7-<i>O</i>-glucoside</td><td>4.9 ± 1.0</td><td>n.d. <sup>1</sup></td><td>n.d. <sup>1</sup></td></tr><tr><td>apigenin</td><td><0.08</td><td>n.d. <sup>1</sup></td><td>n.d. <sup>1</sup></td></tr><tr><td rowspan="3"><i>Zingiber officinale</i> (ginger)</td><td rowspan="3">dried rhizome</td><td rowspan="3">1.7 ± 0.2</td><td>[6]-gingerol</td><td>10.0 ± 0.6</td><td>>500 μg/mL (38%)</td><td>>1.7 mM</td></tr><tr><td>lipoid fraction (GLE)</td><td>~50</td><td>455 ± 19 μg/mL</td><td>-</td></tr><tr><td>hydrophilic fraction (GWE)</td><td>~950</td><td>10.5 ± 1.9 mg/mL</td><td>-</td></tr></table> |
b051cb06a413f6ac81c57d052c66958f516e7f874c4255e94be8a793bee51968.png | complex | <table><tr><td colspan="2">Control sheep (<i>n</i> = 18)</td><td colspan="2">Disease-stressed sheep (<i>n</i> = 10)</td><td colspan="2">Combined groups (<i>n</i> = 10 + 10)</td></tr><tr><td>Gene symbol</td><td>Stability value (<i>M</i>)</td><td>Gene symbol</td><td>Stability value (<i>M</i>)</td><td>Gene symbol</td><td>Stability value (<i>M</i>)</td></tr><tr><td><i>SDHA</i></td><td>0.316</td><td><i>YWHAZ</i></td><td>0.624</td><td><i>SDHA</i></td><td>0.591</td></tr><tr><td><i>YWHAZ</i></td><td>0.342</td><td><i>GAPDH</i></td><td>0.634</td><td><i>YWHAZ</i></td><td>0.593</td></tr><tr><td><i>HPRT</i></td><td>0.344</td><td><i>SDHA</i></td><td>0.667</td><td><i>ACTB</i></td><td>0.596</td></tr><tr><td><i>RPL19</i></td><td>0.361</td><td><i>ACTB</i></td><td>0.701</td><td><i>G6PD</i></td><td>0.666</td></tr><tr><td><i>B2M</i></td><td>0.362</td><td><i>B2M</i></td><td>0.720</td><td><i>GAPDH</i></td><td>0.681</td></tr><tr><td><i>ACTB</i></td><td>0.377</td><td><i>G6PD</i></td><td>0.740</td><td><i>GYPC</i></td><td>0.698</td></tr><tr><td><i>GYPC</i></td><td>0.412</td><td><i>GYPC</i></td><td>0.848</td><td><i>RPL19</i></td><td>0.746</td></tr><tr><td><i>TFRC</i></td><td>0.455</td><td><i>RPL19</i></td><td>1.000</td><td><i>B2M</i></td><td>0.760</td></tr><tr><td><i>G6PD</i></td><td>0.486</td><td><i>HPRT</i></td><td>1.188</td><td><i>HPRT</i></td><td>0.882</td></tr><tr><td><i>PGK1</i></td><td>0.498</td><td><i>PGK1</i></td><td>1.466</td><td><i>TFRC</i></td><td>1.158</td></tr><tr><td><i>GAPDH</i></td><td>0.579</td><td><i>TFRC</i></td><td>1.485</td><td><i>PGK1</i></td><td>1.295</td></tr></table> |
7d6d3f55a48f7c51d691994a79622ab0054442db7e2b85e7f1a858291af741e9.png | simple | <table><tr><td></td><td>Guideline</td><td>Source</td></tr><tr><td>1</td><td>Use Dex/sal for MIF (unless documented why not)</td><td>NICE</td></tr><tr><td>2</td><td>Use fluid with 130–154mmol/l sodium for any resus</td><td>NICE</td></tr><tr><td>3</td><td>Receive 0.6-1.4mmol/Kg/day of maintenance sodium</td><td>NICE</td></tr><tr><td>4</td><td>Give <2.5L/day Dex/saline</td><td>NICE</td></tr><tr><td>5</td><td>Patients with Critical Care induced hypernatraemia</td><td>Local</td></tr></table> |
988417ee791ab36b3648f35a228534566be3b8db30189b85ddef917503f73d34.png | simple | <table><tr><td></td><td>Protein Cnt</td><td>ID Cnt</td><td>Ambiguity</td></tr><tr><td>EPPI</td><td>6,955</td><td>184,633</td><td>26.55</td></tr><tr><td>EPPI species</td><td>6,955</td><td>17,357</td><td>2.50</td></tr><tr><td>TE</td><td>8,539</td><td>103,016</td><td>12.06</td></tr><tr><td>TE species</td><td>8539</td><td>12,705</td><td>1.49</td></tr></table> |
de76f5d5f48140d6fc1ec1234c9886e7bb01d73cbb08101526e414f3d790f9a9.png | simple | <table><tr><td>Parameter</td><td>ITS</td><td>trn<i>L</i>-<i>F</i></td><td>Combines</td></tr><tr><td>Number of accession</td><td>49</td><td>49</td><td>49</td></tr><tr><td>Range of sequence length (bp)</td><td>642–643</td><td>799–801</td><td>1442–1443</td></tr><tr><td>Characters of data matrix</td><td>643</td><td>800</td><td>1443</td></tr><tr><td>Number of constant sites (%)</td><td>584 (90.82%)</td><td>793 (99.13%)</td><td>1377 (96.09%)</td></tr><tr><td>Number of parsimony-information sites (%)</td><td>55 (8.55%)</td><td>7 (0.88%)</td><td>62 (4.32%)</td></tr><tr><td>Number of autopomorphic-information sites (%)</td><td>4 (0.62%)</td><td>0 (0.00%)</td><td>4 (0.28%)</td></tr><tr><td>Consistency index (CI)</td><td>0.892</td><td>0.969</td><td>0.891</td></tr><tr><td>Retention index (RI)</td><td>0.955</td><td>0.958</td><td>0.947</td></tr><tr><td>Rescaled consistency index (RC)</td><td>0.852</td><td>0.928</td><td>0.844</td></tr><tr><td>Homoplasy index (HI)</td><td>0.108</td><td>0.031</td><td>0.109</td></tr></table> |
59ec2086d8759e5ce7b2ae72cf28fe04b9c3f2ec2a8dea6d0938a6df5d44e703.png | simple | <table><tr><td>Hormonal tests</td><td>Values (normal range)</td></tr><tr><td>Plasmatic cortisol</td><td><39 nmol/L (126.8–656.5)</td></tr><tr><td>Plasmatic aldosterone</td><td>14.2 pg/mL (18–232)</td></tr><tr><td>Plasmatic renin</td><td>12.9 <i>μ</i>mU/mL (4–50)</td></tr><tr><td>Plasmatic noradrenaline</td><td>278.2 pg/mL (100–400 lying, 200–700 standing)</td></tr><tr><td>Plasmatic adrenaline</td><td>15.4 pg/mL (<50 lying, <100 standing)</td></tr><tr><td>Plasmatic dopamine</td><td>Nondetectable (0–80)</td></tr><tr><td>Urinary normetanephrines</td><td>289 <i>μ</i>g/g creat (46–256)</td></tr><tr><td>Urinary metanephrines</td><td>98.8 <i>μ</i>g/g creat (27–155)</td></tr><tr><td>Urinary vanillylmandelic acid</td><td>29.1 mg/24 H (1.8–6.7)</td></tr><tr><td>Urinary 5-hydroxyindoleacetic acid</td><td>6.8 mg/24 H (0.7–8.2)</td></tr></table> |
928992160a81ff8561be86c9de6acdbd540683d7779b367b237603f2c8c8fe1f.png | simple | <table><tr><td>GO ID</td><td>Molecular Function</td><td>Observed Gene Count</td><td><i>FDR</i></td></tr><tr><td>GO.0004702</td><td>receptor signaling protein serine/threonine kinase activity</td><td>15</td><td>3.13E-21</td></tr><tr><td>GO.0005515</td><td>protein binding</td><td>7</td><td>2.03E-05</td></tr><tr><td>GO.0004708</td><td>MAP kinase kinase activity</td><td>41</td><td>2.41E-05</td></tr><tr><td>GO.0017137</td><td>Rab GTPase binding</td><td>5</td><td>2.74E-05</td></tr><tr><td>GO.0031489</td><td>myosin V binding</td><td>6</td><td>0.000307</td></tr><tr><td>GO.0017022</td><td>myosin binding</td><td>4</td><td>0.000381</td></tr><tr><td>GO.0004709</td><td>MAP kinase kinase kinase activity</td><td>5</td><td>0.000518</td></tr><tr><td>GO.0005488</td><td>binding</td><td>4</td><td>0.00169</td></tr><tr><td>GO.0017075</td><td>syntaxin-1 binding</td><td>59</td><td>0.00354</td></tr><tr><td>GO.0004707</td><td>MAP kinase activity</td><td>3</td><td>0.00402</td></tr><tr><td>GO.0004674</td><td>protein serine/threonine kinase activity</td><td>3</td><td>0.00636</td></tr><tr><td>GO.0004946</td><td>bombesin receptor activity</td><td>9</td><td>0.0113</td></tr><tr><td>GO.0005102</td><td>receptor binding</td><td>2</td><td>0.0128</td></tr><tr><td>GO.0004908</td><td>interleukin-1 receptor activity</td><td>14</td><td>0.018</td></tr><tr><td>GO.0019905</td><td>syntaxin binding</td><td>2</td><td>0.0215</td></tr><tr><td>GO.0019899</td><td>enzyme binding</td><td>4</td><td>0.0253</td></tr><tr><td>GO.0004871</td><td>signal transducer activity</td><td>15</td><td>0.032</td></tr><tr><td>GO.0005179</td><td>hormone activity</td><td>16</td><td>0.0377</td></tr><tr><td>GO.0060089</td><td>molecular transducer activity</td><td>4</td><td>0.0377</td></tr><tr><td>GO.0086083</td><td>cell adhesive protein binding involved in bundle of Hiscell-Purkinje myocyte communication</td><td>17</td><td>0.0377</td></tr></table> |
b0562fadf1c6d953105d1f905551195a61e8e3aff940a099be180055df4747eb.png | simple | <table><tr><td>Accession NO.</td><td>Strain name</td><td>Year</td><td>Province</td><td>Host</td><td>Length</td><td>Biological sample</td></tr><tr><td>KU641013</td><td>LN1401</td><td>2014</td><td>Liaoning</td><td>Chicken</td><td>2298 bp</td><td>Liver</td></tr><tr><td>KU645511</td><td>LN1402</td><td>2014</td><td>Liaoning</td><td>Chicken</td><td>2298 bp</td><td>Liver</td></tr><tr><td>KU645514</td><td>HB1404</td><td>2014</td><td>Hebei</td><td>Chicken</td><td>2298 bp</td><td>Liver</td></tr><tr><td>KU645516</td><td>HB1517</td><td>2015</td><td>Hebei</td><td>Chicken</td><td>2298 bp</td><td>Liver</td></tr><tr><td>KU645518</td><td>JS1501</td><td>2015</td><td>Jiangsu</td><td>Chicken</td><td>2298 bp</td><td>Bone marrow</td></tr><tr><td>KU645508</td><td>JS1502</td><td>2015</td><td>Jiangsu</td><td>Chicken</td><td>2298 bp</td><td>Bone marrow</td></tr><tr><td>KU645509</td><td>JS1503</td><td>2015</td><td>Jiangsu</td><td>Chicken</td><td>2298 bp</td><td>Bone marrow</td></tr><tr><td>KU645520</td><td>HN1405</td><td>2014</td><td>Henan</td><td>Chicken</td><td>2298 bp</td><td>Liver</td></tr><tr><td>KU645512</td><td>HN1504</td><td>2015</td><td>Henan</td><td>Chicken</td><td>2298 bp</td><td>Liver</td></tr><tr><td>KU645517</td><td>SD1513</td><td>2015</td><td>Neimenggu</td><td>Chicken</td><td>2298 bp</td><td>Bone marrow</td></tr><tr><td>KU645513</td><td>BJ1406</td><td>2014</td><td>Beijing</td><td>Chicken</td><td>2298 bp</td><td>Bone marrow</td></tr><tr><td>KU641014</td><td>JN1503</td><td>2015</td><td>Shandong</td><td>Chicken</td><td>2298 bp</td><td>Bone marrow</td></tr><tr><td>KU645523</td><td>SD1505</td><td>2015</td><td>Shandong</td><td>Chicken</td><td>2298 bp</td><td>Liver</td></tr><tr><td>KU645507</td><td>SD1507</td><td>2015</td><td>Shandong</td><td>Chicken</td><td>2298 bp</td><td>Liver</td></tr><tr><td>KU645519</td><td>SD1508</td><td>2015</td><td>Shandong</td><td>Chicken</td><td>2298 bp</td><td>Bone marrow</td></tr><tr><td>KU645510</td><td>SD1509</td><td>2015</td><td>Shandong</td><td>Chicken</td><td>2298 bp</td><td>Bone marrow</td></tr><tr><td>KU598851</td><td>SD1510</td><td>2015</td><td>Shandong</td><td>Chicken</td><td>2298 bp</td><td>Bone marrow</td></tr><tr><td>KU641015</td><td>SD1511</td><td>2015</td><td>Shandong</td><td>Chicken</td><td>2298 bp</td><td>Liver</td></tr><tr><td>KU645506</td><td>SD1512</td><td>2015</td><td>Shandong</td><td>Chicken</td><td>2298 bp</td><td>Liver</td></tr><tr><td>KU645521</td><td>SD1514</td><td>2015</td><td>Shandong</td><td>Chicken</td><td>2298 bp</td><td>Liver</td></tr><tr><td>KU645515</td><td>SD1515</td><td>2015</td><td>Shandong</td><td>Chicken</td><td>2298 bp</td><td>Liver</td></tr><tr><td>KU645522</td><td>SD1518</td><td>2015</td><td>Shandong</td><td>Chicken</td><td>2298 bp</td><td>Liver</td></tr><tr><td>KU645524</td><td>CAV-Dog</td><td>2015</td><td>Shandong</td><td>Dog</td><td>2298 bp</td><td>Feces</td></tr><tr><td>KU645525</td><td>CAV-Mouse</td><td>2015</td><td>Shandong</td><td>Mouse</td><td>2298 bp</td><td>Feces</td></tr></table> |
4d8a2d812ee4a68e418522e639cf28e16ff333d4b687f0f49eb1056f9ce80986.png | complex | <table><tr><td> </td><td colspan="2"><i>No community sports participation</i></td><td colspan="2"><i>Community sports participation</i></td></tr><tr><td> </td><td>No extracurricular school-based sports participation</td><td>Extracurricular school-based sports participation</td><td>No extracurricular school-based sports participation</td><td>Extracurricular school-based sports participation</td></tr><tr><td> </td><td>β (S.E.)</td><td>β (S.E.)</td><td>β (S.E.)</td><td>β (S.E.)</td></tr><tr><td>Boys</td><td>3.38 (0.10)<sup>a</sup></td><td>3.97 (0.07)<sup>b</sup></td><td>4.28 (0.09)<sup>c</sup></td><td>4.38 (0.04)<sup>c</sup></td></tr><tr><td>Girls</td><td>3.71 (0.08)<sup>a#</sup></td><td>3.74 (0.07)<sup>a#</sup></td><td>4.16 (0.07)<sup>b</sup></td><td>4.28 (0.05)<sup>b#</sup></td></tr></table> |
576c209a37eef79ccf23d4c2046b9cf0bfbac9498d0cc669179524bee7c28ab7.png | simple | <table><tr><td>Country</td><td>Total number of notified TB cases</td><td>TB notification rate per 100 000</td><td>Number of notified TB in foreign<sup>a</sup></td><td>Percentage foreign</td></tr><tr><td>Bulgaria</td><td>2649</td><td>35.0</td><td>2</td><td>0.1</td></tr><tr><td>Estonia</td><td>329</td><td>24.5</td><td>58</td><td>17.6</td></tr><tr><td>Finland</td><td>327</td><td>6.1</td><td>105</td><td>32.1</td></tr><tr><td>Greece</td><td>489</td><td>4.3</td><td>231</td><td>47.2</td></tr><tr><td>Hungary</td><td>1741</td><td>17.4</td><td>21</td><td>1.2</td></tr><tr><td>Latvia</td><td>934</td><td>41.5</td><td>62</td><td>6.6</td></tr><tr><td>Lithuania</td><td>1938</td><td>58.2</td><td>47</td><td>2.4</td></tr><tr><td>Poland</td><td>7509</td><td>19.7</td><td>46</td><td>0.6</td></tr><tr><td>Romania</td><td>21 078</td><td>98.2</td><td>38</td><td>0.2</td></tr><tr><td>Slovakia</td><td>439</td><td>8.1</td><td>8</td><td>1.8</td></tr><tr><td>Total</td><td>37 433</td><td>35.2</td><td>618</td><td>1.7</td></tr></table> |
314b96f06dc29dcfde04f8f97c2a8fdebb126262862258d005fb530f4b97de2d.png | simple | <table><tr><td>Antibiotic</td><td>MIC (μg/ml)</td></tr><tr><td>Ampicillin</td><td>9.8</td></tr><tr><td>Nafcillin</td><td>1.25</td></tr><tr><td>Ciprofloxacin</td><td>25</td></tr><tr><td>Nalidixic acid</td><td>312</td></tr><tr><td>Chloramphenicol</td><td>1.25</td></tr><tr><td>Minocycline</td><td>0.97</td></tr><tr><td>Tetracycline</td><td>> 50</td></tr><tr><td>Erythromycin</td><td>> 10</td></tr><tr><td>Clindamycin</td><td>5</td></tr><tr><td>Kanamycin</td><td>6</td></tr><tr><td>Rifampin</td><td>0.4</td></tr><tr><td>Metronidazole</td><td>0.5</td></tr><tr><td>Vancomycin</td><td>1.0</td></tr></table> |
b114fb90dd28270264c81f12cd5c153394c5ac6bfd8dde402326e5de3aa5ea7c.png | simple | <table><tr><td>Rat</td><td>Target<sup>a</sup></td><td>Angle (°)<sup>b</sup></td><td>int. diam. (μm)<sup>c</sup></td><td>Volume (nL)<sup>d</sup></td><td>Survival (days)<sup>e</sup></td></tr><tr><td>18</td><td>OC2L/ParP</td><td>30</td><td>6.7</td><td>20</td><td>19</td></tr><tr><td>19</td><td>ParP</td><td>30</td><td>7.0</td><td>80</td><td>19</td></tr><tr><td>24</td><td>S1 PMBSF</td><td>45</td><td>7.1</td><td>5</td><td>18</td></tr><tr><td>25</td><td>S1 PMBSF</td><td>45</td><td>7.5</td><td>20</td><td>19</td></tr><tr><td>26</td><td>S1 PMBSF</td><td>45</td><td>7.1</td><td>20</td><td>18</td></tr><tr><td>27</td><td>OC2L</td><td>45</td><td>8.4</td><td>10</td><td>19</td></tr><tr><td>30</td><td>OC2L</td><td>45</td><td>7.2</td><td>10</td><td>18</td></tr><tr><td>31</td><td>ParP</td><td>30</td><td>9.2</td><td>20</td><td>19</td></tr><tr><td>33</td><td>OC2M</td><td>0</td><td>9.0</td><td>20</td><td>13</td></tr><tr><td>35</td><td>S1 trunk</td><td>0</td><td>8.4</td><td>20</td><td>15</td></tr><tr><td>36</td><td>S1 trunk</td><td>0</td><td>6.8</td><td>20</td><td>14</td></tr><tr><td>37</td><td>MCx</td><td>0</td><td>6.7</td><td>20</td><td>13</td></tr><tr><td>38</td><td>MCx</td><td>0</td><td>7.0</td><td>20</td><td>13</td></tr><tr><td>39</td><td>S1 PMBSF</td><td>45</td><td>7.0</td><td>20</td><td>12</td></tr><tr><td>41</td><td>S1 DZ</td><td>45</td><td>8.0</td><td>20</td><td>12</td></tr><tr><td>42</td><td>S1 DZ</td><td>45</td><td>8.3</td><td>20</td><td>11</td></tr></table> |
c251904934a12b6ca00bd55cc6484372552710bab0d3b65702558d5644dc000c.png | simple | <table><tr><td><i>State</i></td><td><i>State Policy Extensiveness*</i></td><td><i>Geographic Area</i></td></tr><tr><td>California</td><td>High</td><td>West</td></tr><tr><td>Georgia</td><td>Middle</td><td>Southeast</td></tr><tr><td>Illinois</td><td>Middle/Low</td><td>Midwest</td></tr><tr><td>Massachusetts</td><td>Low</td><td>Northeast (township oriented)</td></tr><tr><td>New York</td><td>High</td><td>Northeast (not township oriented)</td></tr><tr><td>Texas</td><td>Middle</td><td>South Central</td></tr></table> |
5c0e315385e7086226e1a3663c27a3d874ca2a95734169aacaf4221a01f31169.png | simple | <table><tr><td></td><td>High worry (Group 1) <i>N</i> = 35</td><td>GAD community (Group 2) <i>N</i> = 28</td><td>GAD clients (Group 3) <i>N</i> = 32</td><td>Panic clients (Group 4) <i>N</i> = 24</td><td><i>F</i> (3, 113)</td><td><i>Partial η</i><sup>2</sup></td><td>Post hoc <i>p < .05</i></td></tr><tr><td>Attentional Control Questionnaire</td><td>47.73 (8.12)</td><td>48.60 (6.65)</td><td>42.98 (7.62)</td><td>46.02 (7.92)</td><td>3.10*</td><td>.08</td><td>2 > 3</td></tr><tr><td>Meta Cognitions Questionnaire</td><td>69.32 (11.49)</td><td>72.22 (12.18)</td><td>78.73 (13.66)</td><td>66.55 (17.26)</td><td>4.42**</td><td>.11</td><td>3 > 1, 4</td></tr><tr><td>Worry Domains Questionnaire</td><td>21.43 (9.27)</td><td>24.29 (6.70)</td><td>27.31 (6.07)</td><td>19.63 (8.87)</td><td>5.11**</td><td>.12</td><td>3 > 1, 4</td></tr></table> |
c22a4b87b78074eb9f62522ddb59b472e03f665a7325762067a5a7509d6d6fbe.png | simple | <table><tr><td>Antigen</td><td>Clone</td><td>Supplier</td><td>Dilution</td><td>Antigen retrieval</td></tr><tr><td>PR</td><td>Mouse Monoclonal, 16</td><td>Leica Microsystems</td><td>1:100</td><td>citrate</td></tr><tr><td>ER</td><td>Mouse Monoclonal, 6F11</td><td>Leica Microsystems</td><td>1:100</td><td>citrate</td></tr><tr><td>Vim</td><td>Mouse monoclonal, V9</td><td>Leica Microsystems</td><td>1:400</td><td>citrate</td></tr><tr><td>CEA</td><td>Mouse monoclonal, 12-140-10</td><td>Leica Microsystems</td><td>1:100</td><td>trypsin</td></tr></table> |
74047561f1069e6fff80a0b9f8e7fac0b49db56ba0f4452385594826f10a0ea3.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2">Unadjusted OR (95% CI)</td><td>Model 1</td><td>Model 2</td><td>Model 3</td></tr><tr><td>Adjusted OR (95% CI)*</td><td>Adjusted OR (95% CI)*</td><td>Adjusted OR (95% CI)*</td></tr><tr><td>All Years</td><td>3.14 (2.74 to 3.60)</td><td>1.89 (1.65 to 2.17)</td><td>1.87 (1.62 to 2.17)</td><td>1.87 (1.61 to 2.16)</td></tr><tr><td>2004 only</td><td>4.68 (3.07 to 7.13)</td><td>2.91 (1.69 to 4.99)</td><td>2.96 (1.74 to 5.02)</td><td>2.95 (1.74 to 5.00)</td></tr><tr><td>2005 only</td><td>3.78 (2.45 to 5.84)</td><td>2.91 (1.90 to 4.45)</td><td>2.82 (1.73 to 4.59)</td><td>2.82 (1.74 to 4.56)</td></tr><tr><td>2006 only</td><td>2.41 (1.82 to 3.19)</td><td>1.84 (1.43 to 2.38)</td><td>1.79 (1.35 to 2.37)</td><td>1.77 (1.33 to 2.34)</td></tr><tr><td>2007 only</td><td>2.40 (1.91 to 3.01)</td><td>1.80 (1.46 to 2.23)</td><td>1.94 (1.59 to 2.36)</td><td>1.93 (1.58 to 2.35)</td></tr><tr><td>2008 only</td><td>2.68 (2.15 to 3.35)</td><td>1.95 (1.58 to 2.39)</td><td>1.92 (1.53 to 2.41)</td><td>1.92 (1.53 to 2.41)</td></tr><tr><td>2009 only</td><td>2.45 (1.93 to 3.11)</td><td>1.70 (1.35 to 2.14)</td><td>1.67 (1.26 to 2.20)</td><td>1.67 (1.26 to 2.20)</td></tr></table> |
bd45eebb9b2fa6a62c8ce27dc738264c9f2a65314d05b8319533e14f9dc87089.png | simple | <table><tr><td>Variables</td><td>Univentricular</td><td>Biventricular</td><td>P</td></tr><tr><td>PDA flow* (L/min/m<sup>2</sup>)</td><td>1.70 (0.56 to 2.53)</td><td>0.61 (−1.48 to 3.23)</td><td>0.0147</td></tr><tr><td>AAo flow (L/min/m<sup>2</sup>)</td><td>0.56 (−0.19 to 1.08)</td><td>1.82 (−0.16 to 2.92)</td><td>0.0006</td></tr><tr><td>Contribution of PDA to Qs (%)</td><td>56.59 (39.77 to 100)</td><td>24.14 (−87.16 to 100)</td><td>0.0013</td></tr><tr><td>LVEDVi (ml/m<sup>2</sup>)</td><td>15.75 (11.8 to 30.3)</td><td>27 (17.7 to 71.2)</td><td>0.024</td></tr><tr><td>AR ratio</td><td>0.72 ± 0.14 (0.52 to 0.92)</td><td>0.54 ± 0.17 (0.28 to 0.89)</td><td>0.01</td></tr></table> |
e401cb80ce2fdaa397b12c900a7f2c8776b393a7141f7decfe12e39cfd02ddad.png | complex | <table><tr><td>Drug</td><td colspan="8">Paw volume increase over time (ml ± SD) and effect (% of negative control)</td></tr><tr><td></td><td>1 hr</td><td></td><td>3 hr</td><td></td><td>5 hr</td><td></td><td>7 hr</td><td></td></tr><tr><td>Saline</td><td>0.63 ± 0.09</td><td></td><td>0.92 ± 0.14</td><td></td><td>0.84 ± 0.13</td><td></td><td>0.81 ± 0.14</td><td></td></tr><tr><td>Arnica D4</td><td>0.59 ± 0.15</td><td>-7</td><td>0.90 ± 0.14</td><td>-2</td><td>0.86 ± 0.15</td><td>3</td><td>0.74 ± 0.15</td><td>-8</td></tr><tr><td>Apis D4</td><td>0.57 ± 0.08</td><td>-10</td><td>0.83 ± 0.14</td><td>-10</td><td>0.80 ± 0.13</td><td>-5</td><td>0.67 ± 0.12</td><td>-17</td></tr><tr><td>Atropa D4</td><td>0.61 ± 0.09</td><td>-4</td><td>0.96 ± 0.09</td><td>4</td><td>0.81 ± 0.10</td><td>-3</td><td>0.74 ± 0.15</td><td>-9</td></tr><tr><td>Hamamelis D4</td><td>0.62 ± 0.13</td><td>-3</td><td>0.95 ± 0.15</td><td>3</td><td>0.87 ± 0.17</td><td>5</td><td>0.69 ± 0.12</td><td>-15</td></tr><tr><td>Lachesis D6</td><td>0.64 ± 0.16</td><td>1</td><td>0.86 ± 0.22</td><td>-7</td><td>0.85 ± 0.20</td><td>2</td><td>0.81 ± 0.12</td><td>0</td></tr><tr><td>Phosphorus D6</td><td>0.59 ± 0.09</td><td>-8</td><td>0.94 ± 0.13</td><td>2</td><td>0.88 ± 0.16</td><td>6</td><td>0.74 ± 0.13</td><td>-9</td></tr><tr><td>Indomethacin i.m.</td><td>0.54 ± 0.12</td><td>-14</td><td>0.69 ± 0.12</td><td>-25</td><td>0.63 ± 0.11</td><td>-25</td><td>0.49 ± 0.05</td><td>-40</td></tr></table> |
291e2dc77f329a57e20cd25fc622003cf8f7d67832a7baaa4c2cf3e9faba10c4.png | complex | <table><tr><td>Condition</td><td>SMM and M, number (%)</td><td>Maternal deaths</td></tr><tr><td>Peritonitis</td><td>58(30)</td><td>16</td></tr><tr><td>Hemorrhage</td><td>45(18.7)</td><td>10</td></tr><tr><td>Hypertensive disease</td><td>55(28.6)</td><td>9</td></tr><tr><td>Cancer</td><td rowspan="4">5(1.5)</td><td rowspan="4">4</td></tr><tr><td> -pancreatic (1)</td></tr><tr><td> -breast cancer (2)</td></tr><tr><td> -leukemia (1)</td></tr><tr><td>Cardiomyopathy</td><td>7(3.6)</td><td>3</td></tr><tr><td>Malaria</td><td>6(3)</td><td>2</td></tr><tr><td>Pulmonary Embolism</td><td>2 (2.2)</td><td>0</td></tr><tr><td>Pulmonary Disease</td><td>1 (1.1)</td><td>1</td></tr><tr><td>Diabetes</td><td rowspan="3">2(2.2)</td><td rowspan="3"></td></tr><tr><td> -severe hypoglycemia,</td></tr><tr><td> -diabetic coma</td></tr><tr><td>Hepatic Disease</td><td rowspan="3">2(2.2)</td><td rowspan="3">0</td></tr><tr><td> -cirrhosis</td></tr><tr><td> -hepatic abscess</td></tr><tr><td>Neurologic</td><td rowspan="3">2(2.2)</td><td rowspan="3"></td></tr><tr><td> -stroke postpartum</td></tr><tr><td> -coma of unknown etiology)</td></tr><tr><td>Anesthetic complications</td><td>2(2.2)</td><td></td></tr><tr><td>Epilepsy</td><td>1 (1.1)</td><td>0</td></tr><tr><td>Other*</td><td>7(3.6)</td><td>5</td></tr><tr><td>Total number of patients experiencing severe maternal morbidity + mortality<sup>a</sup></td><td>192</td><td>50</td></tr></table> |
6fc256cdf81fa2f652b884836bcafd647309b5302e90d7c7524dce68d01ecadc.png | complex | <table><tr><td>Source</td><td colspan="3">1</td><td colspan="4">2</td><td colspan="3">3</td><td>4</td></tr><tr><td>Farm</td><td>A</td><td></td><td></td><td>B</td><td></td><td>D</td><td>E</td><td>C</td><td>F</td><td></td><td>G</td></tr><tr><td>Health status</td><td>SPF</td><td></td><td></td><td>SPF</td><td></td><td colspan="2">Non-SPF</td><td>SPF</td><td colspan="2">Non-SPF</td><td>Non-SPF</td></tr><tr><td>Generation</td><td>G1</td><td>G2</td><td>GX</td><td>G1</td><td>G2</td><td>G2</td><td>GX</td><td>G1</td><td>G2</td><td>GX</td><td>GX</td></tr><tr><td>No. pigs:</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Performance</td><td>47</td><td>684</td><td>373</td><td>92</td><td>259</td><td>148</td><td>300</td><td>94</td><td>398</td><td>72</td><td>175</td></tr><tr><td>Immune traits</td><td>47</td><td>0</td><td>373</td><td>92</td><td>68</td><td>59</td><td>300</td><td>94</td><td>0</td><td>72</td><td>175</td></tr><tr><td>APP</td><td>0</td><td>0</td><td>373</td><td>0</td><td>0</td><td>0</td><td>300</td><td>0</td><td>0</td><td>72</td><td>175</td></tr><tr><td>No. groups:</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Sires</td><td>21</td><td>4<sup>2</sup></td><td>27</td><td>23</td><td>5 <sup>2,3</sup></td><td>5 <sup>2,3</sup></td><td>17</td><td>10</td><td>5<sup>2</sup></td><td>11</td><td>55</td></tr><tr><td>Full-sib families</td><td>33</td><td>155</td><td>200</td><td>53</td><td>53</td><td>53</td><td>121</td><td>19</td><td>53</td><td>18</td><td>72</td></tr><tr><td>Genetic lines</td><td>8</td><td>4</td><td>2</td><td>1</td><td>1</td><td>1</td><td>1</td><td>1</td><td>1</td><td>8</td><td>13</td></tr><tr><td>Breed</td><td>LW</td><td>LW</td><td>LW</td><td>LW</td><td>LW</td><td>LW</td><td>LW</td><td>LW</td><td>LW</td><td>LR</td><td>LW</td></tr></table> |
bd1d513d4ddfcfb333597d3b0d9c9120ad44dd3fe8a2b53145ee293628e1a057.png | complex | <table><tr><td rowspan="2" colspan="2">Variables</td><td colspan="5">At the time of enrollment</td><td colspan="5">Follow-up</td></tr><tr><td>Cluster 1</td><td>Cluster 2</td><td>Cluster 3</td><td>Cluster 4</td><td><i>P</i> value</td><td>Cluster 1</td><td>Cluster 2</td><td>Cluster 3</td><td>Cluster 4</td><td><i>P</i> value</td></tr><tr><td rowspan="2">Total serum IgE levels (IU/mL)</td><td>mean (N)</td><td>746.8 (51)</td><td>306.1 (40)</td><td>1238.0 (28)</td><td>175.0 (111)</td><td><0.001</td><td>378.9 (35)</td><td>148.7 (22)</td><td>447.7 (17)</td><td>77.2 (68)</td><td><0.001</td></tr><tr><td>95% CI</td><td>519.3–974.3</td><td>125.4–486.9</td><td>738.0–1738.0</td><td>87.7–262.6</td><td></td><td>296.8–460.9</td><td>86.0–211.4</td><td>268.3–627.1</td><td>45.0–109.5</td><td></td></tr><tr><td rowspan="2">Blood eosinophil, %</td><td>mean (N)</td><td>5.7 (51)</td><td>5.3 (40)</td><td>6.2 (29)</td><td>3.6 (112)</td><td><0.001</td><td>4.4 (35)</td><td>3.8 (22)</td><td>5.4 (17)</td><td>3.1 (69)</td><td>0.002</td></tr><tr><td>95% CI</td><td>4.6–6.8</td><td>4.1–6.5</td><td>4.9–7.6</td><td>2.8–4.3</td><td></td><td>3.5–5.3</td><td>2.5–5.1</td><td>3.8–7.0</td><td>2.7–3.6</td><td></td></tr></table> |
b3555d8e7f4450a1b8bbe1dab67c955ca46a51cefe1bcc7eff40b27c440d7097.png | complex | <table><tr><td>Variable</td><td colspan="2">Group at the beginning of treatment</td><td colspan="2">Group at the definitive brace removal</td></tr><tr><td>Gender</td><td>Girls</td><td>87 (97%)</td><td>Girls</td><td>87 (97%)</td></tr><tr><td></td><td>Boys</td><td>3 (3%)</td><td>Boys</td><td>3 (3%)</td></tr><tr><td>Mean age</td><td>Girls</td><td>13 years</td><td>Girls</td><td>15 years 10 months</td></tr><tr><td></td><td>Boys</td><td>13 years 4 months</td><td>Boys</td><td>15 years 8 months</td></tr><tr><td>Curvative type</td><td>Double-major</td><td>67 (74.4%)</td><td>Double-major</td><td>67 (77.0%)</td></tr><tr><td></td><td>Lumbar</td><td>3 (3.3%)</td><td>Lumbar</td><td>-</td></tr><tr><td></td><td>Thoracic</td><td>7 (7.8%)</td><td>Thoracic</td><td>7 (8.0%)</td></tr><tr><td></td><td>Thoraco- lumbar</td><td>13 (14.4%)</td><td>Thoraco-lumbar</td><td>13 (14.9%)</td></tr><tr><td>Cobb angle</td><td>Double-major</td><td>20.9° 20,0°</td><td>Double-major</td><td>20.6° 16.9°</td></tr><tr><td></td><td>Thoracic</td><td>20.3°</td><td>Thoracic</td><td>17.3°</td></tr><tr><td></td><td>Thoraco- lumbar</td><td>24.1°</td><td>Thoraco- lumbar</td><td>21.5°</td></tr><tr><td>SkeletalMaturity</td><td>Risser 0</td><td>33 (36.7%)</td><td colspan="2">Achieved</td></tr><tr><td></td><td>Risser 1</td><td>15 (16.7%)</td><td></td><td></td></tr><tr><td></td><td>Risser 2</td><td>21 (23.3%)</td><td></td><td></td></tr><tr><td></td><td>Risser 3</td><td>14 (15.6%)</td><td></td><td></td></tr><tr><td></td><td>Risser 4</td><td>7 (7.8%)</td><td></td><td></td></tr><tr><td>Theoretical VC</td><td>Girls</td><td>3.2 litres</td><td>Girls</td><td>3.6 litres</td></tr><tr><td></td><td>Boys</td><td>4.1 litres</td><td>Boys</td><td>4.5 litres</td></tr><tr><td>FVC</td><td>Girls</td><td>2.3 litres</td><td>Girls</td><td>2.7 litres</td></tr><tr><td></td><td>Boys</td><td>2.9 litres</td><td>Boys</td><td>4 litres</td></tr></table> |
49448717939f80892141346ace198e444708f97e36c4fec6b644d079ab949d45.png | complex | <table><tr><td></td><td></td><td>Total <i>N</i> = 456 n (%)</td><td>RV + <i>N</i> = 201 n (%)</td><td>RV – <i>N</i> = 253 n (%)</td><td><i>p</i>-value</td></tr><tr><td rowspan="2">Gender</td><td>Male</td><td>236 (51.9)</td><td>95 (47.3)</td><td>140 (55.6)</td><td rowspan="2">0.079</td></tr><tr><td>Female</td><td>219 (48.1)</td><td>106 (52.7)</td><td>112 (44.4)</td></tr><tr><td rowspan="3">Age-groups (3-groups)</td><td>0–12</td><td>166 (36.4)</td><td>79 (39.3)</td><td>87 (34.4)</td><td rowspan="3">0.063</td></tr><tr><td>12–24</td><td>184 (40.4)</td><td>86 (42.8)</td><td>97 (38.3)</td></tr><tr><td>24–36</td><td>106 (23.2)</td><td>36 (17.9)</td><td>69 (27.3)</td></tr><tr><td rowspan="5">Age-groups (5-groups)</td><td>0–2</td><td>10 (2.2)</td><td>4 (2.0)</td><td>6 (2.4)</td><td rowspan="5">0.028</td></tr><tr><td>2–6</td><td>42 (9.2)</td><td>14 (7.0)</td><td>28 (11.1)</td></tr><tr><td>6–12</td><td>114 (25.0)</td><td>61 (30.3)</td><td>53 (20.9)</td></tr><tr><td>12–24</td><td>184 (40.4)</td><td>86 (42.8)</td><td>97 (38.3)</td></tr><tr><td>24–36</td><td>106 (23.2)</td><td>36 (17.9)</td><td>69 (27.3)</td></tr><tr><td rowspan="3">RV vaccination</td><td>Complete</td><td>109 (24.5)</td><td>20 (10.0)</td><td>89 (36.6)</td><td rowspan="3">0.001</td></tr><tr><td>Partial</td><td>15 (3.4)</td><td>2 (1.0)</td><td>13 (5.3)</td></tr><tr><td>None</td><td>321 (72.1)</td><td>179 (89.1)</td><td>141 (58.0)</td></tr><tr><td>Breastfeeding</td><td>Yes</td><td>376 (83.0)</td><td>171 (85.9)</td><td>204 (80.6)</td><td>0.137</td></tr><tr><td>Continue with breastfeeding</td><td>Yes</td><td>51 (13.6)</td><td>30 (17.5)</td><td>21 (10.3)</td><td>0.041</td></tr><tr><td rowspan="4">Number of previous episodes of AGE</td><td>1</td><td>80 (52.3)</td><td>41 (67.2)</td><td>39 (42.9)</td><td rowspan="4">0.045</td></tr><tr><td>2</td><td>42 (27.5)</td><td>13 (21.3)</td><td>29 (27.5)</td></tr><tr><td>3</td><td>18 (11.8)</td><td>5 (8.2)</td><td>13 (11.8)</td></tr><tr><td>>3</td><td>13<sup>a</sup> (8.5)</td><td>2 (3.2)</td><td>10 (11.0)</td></tr><tr><td>Previous hospitalizations for AGE</td><td>Yes</td><td>9 (2.0)</td><td>3 (1.5)</td><td>6 (2.4)</td><td>0.737</td></tr><tr><td>Attendance at day care center (currently)</td><td>Yes</td><td>210 (46.6)</td><td>80 (40.2)</td><td>128 (51.2)</td><td>0.020</td></tr></table> |
3337ae7f11afc42c3d98d6b146d8a0b96b1f0730538e80686cea663ea15379d8.png | complex | <table><tr><td>Characteristics</td><td>Metabolically Normal Obesity <i>n</i> = 114 (%)</td><td>Metabolically Abnormal Obesity <i>n</i> = 36 (%)</td><td><i>p</i>-value</td><td><i>p*</i></td></tr><tr><td>Age (years, median, range)</td><td>8,85 (5,92–11,10)</td><td>11,12 (9,93–13,36)</td><td>< 0,001</td><td></td></tr><tr><td>Sex</td><td></td><td></td><td>0.09</td><td rowspan="3"></td></tr><tr><td> Boys</td><td>63 (55)</td><td>14 (39)</td><td></td></tr><tr><td> Girls</td><td>51(45)</td><td>22 (61)</td><td></td></tr><tr><td>Birth weight (Kg, median, range)</td><td>3.310 (3.020–3.560)</td><td>3.175 (2.940–3.580)</td><td>0.5</td><td></td></tr><tr><td>Comorbidity</td><td></td><td></td><td>0.9</td><td rowspan="3"></td></tr><tr><td> No</td><td>104 (91)</td><td>33 (92)</td><td></td></tr><tr><td> Yes</td><td>10 (9)</td><td>3 (8)</td><td></td></tr><tr><td>Mother’s obesity (<i>n</i> = 123)</td><td></td><td></td><td>0.003</td><td>0,02</td></tr><tr><td> Nonobese (BMI < 25 Kg/m2)</td><td>19 (20)</td><td>1 (4)</td><td></td><td rowspan="3"></td></tr><tr><td> Overweight (25 < BMI < 30 Kg/m2)</td><td>32 (34)</td><td>4 (14)</td><td></td></tr><tr><td> Obese (BMI?30/Kg/m2)</td><td>44 (46)</td><td>23 (82)</td><td></td></tr><tr><td>Father’s obesity (<i>n</i> = 68)</td><td></td><td></td><td>0.6</td><td rowspan="4"></td></tr><tr><td> Nonobese (BMI < 25 Kg/m2)</td><td>10 (18)</td><td>3 (25)</td><td></td></tr><tr><td> Overweight (25 < BMI < 30 Kg/m2)</td><td>21 (38)</td><td>4 (33)</td><td></td></tr><tr><td> Obese (BMI?30 /Kg/m2)</td><td>25 (45)</td><td>5 (42)</td><td></td></tr><tr><td colspan="5">Term pregnancy (n = 123)</td></tr><tr><td> Full-term birth</td><td>91 (97)</td><td>28 (97</td><td>0.9</td><td rowspan="2"></td></tr><tr><td> Premature birth</td><td>3 (3)</td><td>1 (3)</td><td></td></tr><tr><td>Feeding (<i>n</i> = 129)</td><td></td><td></td><td>0.1</td><td rowspan="3"></td></tr><tr><td> Breastfeeding</td><td>25 (26)</td><td>4 (13)</td><td></td></tr><tr><td> Formula or mixed</td><td>73 (74)</td><td>27 (87)</td><td></td></tr><tr><td>BMI (Z-score, median, range)</td><td>4,42[3,94–5,28]</td><td>4,9[4,05–5,38]</td><td>< 0,001</td><td></td></tr><tr><td colspan="5">Overweight or obesity</td></tr><tr><td> Overweight</td><td>6 (5)</td><td>0 (0)</td><td>0.6</td><td rowspan="2"></td></tr><tr><td> Obesity</td><td>108 (95)</td><td>36 (100)</td><td></td></tr><tr><td>Systolic blood pressure (mmHg, median, range)</td><td>111 (106–121)</td><td>133.5 (123.5–138.5)</td><td>0.001</td><td rowspan="2"></td></tr><tr><td>Diastolic blood pressure (mmHg, median, range)</td><td>70 (66–77)</td><td>79.5 (72.5–84.5)</td><td>0.06</td></tr><tr><td>Waist circumference (cm, median, range)</td><td>85 (78–96)</td><td>103 (94–109)</td><td>< 0.001</td><td>< 0.001</td></tr><tr><td>Waist-to-height ratio</td><td>0.62 [0.58–0.67]</td><td>0.66 [0.61–0.69]</td><td>0.3</td><td></td></tr></table> |
97c9b679db075d5aec99f64656064822db05c85148277e1781d16e4ea8e574ec.png | simple | <table><tr><td>Setting</td><td>Level</td><td>Type of participants</td><td>Type of interviews</td><td>Number of interviews</td></tr><tr><td>MoH</td><td>Principal</td><td>Policy makers</td><td>Key informant</td><td>3</td></tr><tr><td>HSB</td><td>Principal</td><td>Policy makers</td><td>Key informant</td><td>2</td></tr><tr><td>ZACH</td><td>Principal</td><td>Policy makers</td><td>Key informant</td><td>1</td></tr><tr><td>MEPMO</td><td>Principal</td><td>Policy makers</td><td>Key informant</td><td>1</td></tr><tr><td>ELB/local clinics</td><td>Local/agent</td><td>Policy makers</td><td>Key informant</td><td>3</td></tr><tr><td>Local clinics</td><td>Local/agent</td><td>Sisters in charge/personnel managers</td><td>In-depth</td><td>7</td></tr><tr><td>Local clinics</td><td>Local/agent</td><td>Healthcare workers</td><td>Sample</td><td>19</td></tr><tr><td>Community</td><td>Local/agent</td><td>Community members</td><td>Focus group discussions (10 people each)</td><td>5</td></tr></table> |
ebf13677b665771ac9063720e282b92898be723b97971b129cfdeb266c7f135d.png | simple | <table><tr><td> </td><td>SLE</td><td>HD</td></tr><tr><td>Number of cases</td><td>103</td><td>65</td></tr><tr><td>Number of visits (2 or more)</td><td>180 (60)</td><td>65 (0)</td></tr><tr><td>Mean age, years (range)</td><td>44 (25–68)</td><td>33 (19–59)</td></tr><tr><td>Sex, female/male/unknown, n</td><td>90/13/0</td><td>31/9/24</td></tr><tr><td>Race, AA/EA/LA/AsA/IrA/unknown<sup>1</sup>, n</td><td>35/50/12/3/3/0</td><td>10/18/6/3/2/25</td></tr><tr><td>Race by visit (AA/EA/LA/AsA/IrA/unknown)<sup>1</sup>, n</td><td>64/86/20/7/3/0</td><td>10/18/6/3/2/25</td></tr><tr><td>Active/inactive by SLEDAI, number of patients</td><td>49/131</td><td>N/A</td></tr><tr><td>Main clinical features, number of patients</td><td> </td><td> </td></tr><tr><td>Malar rash</td><td>9/94</td><td>N/A</td></tr><tr><td>Discoid lesions</td><td>2/101</td><td>N/A</td></tr><tr><td>Photosensitivity</td><td>8/95</td><td>N/A</td></tr><tr><td>Oral ulcers</td><td>7/96</td><td>N/A</td></tr><tr><td>Arthritis</td><td>17/86</td><td>N/A</td></tr><tr><td>Serositis</td><td>4/99</td><td>N/A</td></tr><tr><td>Pleuritis</td><td>5/98</td><td>N/A</td></tr><tr><td>Nephritis</td><td>49/54</td><td>N/A</td></tr><tr><td>Seizures</td><td>2/101</td><td>N/A</td></tr><tr><td>Psychosis</td><td>1/102</td><td>N/A</td></tr></table> |
fcea627a7495eb2c475d7ddd556a2400078e898836b4b4018ae14bb654f66fc1.png | simple | <table><tr><td></td><td>Wildtype</td><td>Mahidolheterozygote</td><td>Chinese-4heterozygote</td><td>Kaipingheterozygote</td><td>Mahidolhomozygote</td><td>Mahidol-Canton</td><td>Total</td><td>Overall allelicfrequency ofall variants</td><td>Allelic frequencyof Mahidol variant</td></tr><tr><td>Sgaw Karen</td><td>91</td><td>47</td><td>1</td><td>1</td><td>7</td><td>0</td><td>147</td><td>21.4%</td><td>20.7%</td></tr><tr><td>Poe Karen</td><td>34</td><td>12</td><td>0</td><td>1</td><td>4</td><td>0</td><td>51</td><td>20.6%</td><td>19.6%</td></tr><tr><td>Burman</td><td>67</td><td>9</td><td>1</td><td>2</td><td>0</td><td>1</td><td>80</td><td>8.8%</td><td>6.3%</td></tr><tr><td>“Muslim”</td><td>11</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>11</td><td>0.0%</td><td>0.0%</td></tr><tr><td>Other</td><td>6</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td><td>7</td><td>7.1%</td><td>7.1%</td></tr><tr><td>“Mixed”</td><td>16</td><td>5</td><td>0</td><td>0</td><td>0</td><td>0</td><td>21</td><td>11.9%</td><td>11.9%</td></tr><tr><td>Total</td><td>225</td><td>74</td><td>2</td><td>4</td><td>11</td><td>1</td><td>317</td><td>16.3%</td><td>15.3%</td></tr></table> |
bc8330868c514c6a28d4f8cf08952fb67a2d05df55cd6b0b0ceb63685a0c1262.png | simple | <table><tr><td>Therapeutic modalities</td><td>Frequency (%)</td></tr><tr><td>Concomitant radio-chemotherapy</td><td>66 (43.7)</td></tr><tr><td>Concomitant radio chemotherapy followed by surgery</td><td>22 (14.9)</td></tr><tr><td>Exclusive radiotherapy</td><td>12 (7.9)</td></tr><tr><td>Surgery followed by exclusive radiotherapy</td><td>25 (16.6)</td></tr><tr><td>Surgery followed by concomitant radio chemotherapy</td><td>21 (13.9)</td></tr><tr><td>Surgery alone</td><td>4 (2.6)</td></tr><tr><td>Palliative chemotherapy</td><td>1 (0.7)</td></tr></table> |
78775b711fce5c985b91ad482602f653f95879b7e52fe5047c6e70aa32cc3715.png | simple | <table><tr><td>Description</td><td>Notation</td><td>Baseline value</td><td>Reference</td></tr><tr><td>Population size</td><td><i>N</i></td><td>100,000</td><td>assumed</td></tr><tr><td>Average life expectancy at birth</td><td>1/<i>μ</i></td><td>69.4 (years)</td><td>[1]</td></tr><tr><td>Transmission coefficient of obesity</td><td><i>β</i></td><td>2.96 × 10<sup>-7</sup> (per year)</td><td>[12]</td></tr><tr><td>Non-contagious hazard of obesity</td><td><i>ε</i></td><td>0.012 (per year)</td><td>[13]</td></tr><tr><td>Relative hazard of obesity among ex-obese</td><td><i>σ</i></td><td>8.0</td><td>[12]</td></tr><tr><td>Average duration of obesity</td><td>1/<i>γ</i></td><td>35.8 (years)</td><td>[13]</td></tr></table> |
06575bc04911d377bf3c51c4039db123d233e83f0f4513f11d84cfdba92d9b3f.png | complex | <table><tr><td></td><td>Curative or not</td><td>N</td><td>Mean</td><td>Std. deviation</td><td>Std. error mean</td></tr><tr><td colspan="6">Group statistics</td></tr><tr><td rowspan="2"> Total HNA score</td><td>Curative</td><td>3671</td><td>26.08</td><td>34.312</td><td>.566</td></tr><tr><td>Not curative</td><td>1293</td><td>41.13</td><td>41.040</td><td>1.141</td></tr><tr><td rowspan="2"> Number of problems</td><td>Curative</td><td>3675</td><td>5.86</td><td>5.460</td><td>.090</td></tr><tr><td>Not curative</td><td>1297</td><td>7.64</td><td>6.576</td><td>.183</td></tr><tr><td rowspan="2"> Minutes and seconds for HNA completion</td><td>Curative</td><td>3675</td><td>6 min 56 s</td><td>5 min 53 s</td><td>6 s</td></tr><tr><td>Not curative</td><td>1297</td><td>8 min 36 s</td><td>7 min 5 s</td><td>11 s</td></tr></table> |
aaf3d30cafe71a5e6876befec0bebb429c0cd05afc7b5281db23c4ee9f4dab5d.png | complex | <table><tr><td rowspan="2">Sample</td><td colspan="2">Litter Concentrations</td><td colspan="2">Application Rates</td><td rowspan="2">Analyst</td></tr><tr><td>Fe</td><td>As</td><td>Fe</td><td>As</td></tr><tr><td>Litter from 2012</td><td>2200 ± 252</td><td>2.5 ± 3.0</td><td>7.41</td><td>0.009</td><td>This study</td></tr><tr><td>Litter from 2014</td><td>1106 ± 89</td><td>5.2 ± 0.4</td><td>3.73</td><td>0.013</td><td>This study</td></tr></table> |
877ab340d7cd3e6024ea94747b3b88d175a12c0fb513dc25e2c2c02932f33f2c.png | simple | <table><tr><td></td><td>TGCT</td><td>HD</td><td>NHL</td><td>L</td><td>S</td><td>BT</td><td>Behcet</td><td>MS</td></tr><tr><td><i>n</i></td><td>2315</td><td>1175</td><td>439</td><td>360</td><td>208</td><td>40</td><td>68</td><td>73</td></tr><tr><td>Age (year, median)</td><td>28.8</td><td>26</td><td>28.8</td><td>27.5</td><td>23.1</td><td>28.2</td><td>29.7</td><td>30.3</td></tr><tr><td>% ≤ 20 year-old</td><td>7.1</td><td>19.1</td><td>15.7</td><td>20.6</td><td>35.6</td><td>25</td><td>5.9</td><td>5.5</td></tr><tr><td>% Childless</td><td>53</td><td>61.3</td><td>54.1</td><td>54.1</td><td>75.4</td><td>72.5</td><td>39.7</td><td>24.7</td></tr></table> |
0381e7afae7e242f60a060c821c3391d88f13728c1b8e234452335d1223ff1fd.png | simple | <table><tr><td>Time between onset of symptoms and care at CAMH clinic</td><td>n (%)</td></tr><tr><td>Within a week</td><td>29 (17.5)</td></tr><tr><td>More than a week but less than a month</td><td>7 (4.2)</td></tr><tr><td>1–6 months</td><td>50 (30.1)</td></tr><tr><td>7–12 months</td><td>22 (13.2)</td></tr><tr><td>13–24 months</td><td>24 (14.5)</td></tr><tr><td>25–36 months</td><td>14 (8.4)</td></tr><tr><td>37–48 months</td><td>8 (4.8)</td></tr><tr><td>49 months/more</td><td>12 (7.2)</td></tr></table> |
ac5884b275e1a0055b43ba27cb67c03bf4be3a2229eccaed3fa3fac3932178cd.png | simple | <table><tr><td>Characteristics</td><td><i>N</i> (%)</td></tr><tr><td>Sex</td><td> </td></tr><tr><td> Male</td><td>1087 (53.9%)</td></tr><tr><td> Female</td><td>931 (46.1%)</td></tr><tr><td>Age (years)</td><td> </td></tr><tr><td> <3</td><td>65 (3.2%)</td></tr><tr><td> 3 to <4</td><td>294 (14.6%)</td></tr><tr><td> 4 to <5</td><td>604 (29.9%)</td></tr><tr><td> 5 to <6</td><td>670 (33.2%)</td></tr><tr><td> ≥6</td><td>385 (19.1%)</td></tr><tr><td>Residence</td><td> </td></tr><tr><td> Outlander</td><td>765 (37.9%)</td></tr><tr><td> Native</td><td>1253 (62.1%)</td></tr><tr><td>Town</td><td> </td></tr><tr><td> Fengjiang</td><td>1264 (62.6%)</td></tr><tr><td> Pengjie</td><td>754 (37.4%)</td></tr><tr><td>Father's education</td><td> </td></tr><tr><td> Primary school</td><td>585 (29.0%)</td></tr><tr><td> Middle and high school</td><td>1335 (66.2%)</td></tr><tr><td> College or higher</td><td>98 (4.9%)</td></tr><tr><td>Father's occupation</td><td> </td></tr><tr><td> Lead-related</td><td>1033 (51.2%)</td></tr><tr><td> Not lead-related</td><td>985 (48.8%)</td></tr><tr><td>Mother's education</td><td> </td></tr><tr><td> Primary school</td><td>709 (35.1%)</td></tr><tr><td> Middle and high school</td><td>1197 (59.3%)</td></tr><tr><td> College or higher</td><td>112 (5.6%)</td></tr><tr><td>Mother's occupation</td><td> </td></tr><tr><td> Lead-related</td><td>926 (45.9%)</td></tr><tr><td> Not lead-related</td><td>1092 (54.1%)</td></tr><tr><td>Cares' education</td><td> </td></tr><tr><td> Primary school</td><td>877 (43.5%)</td></tr><tr><td> Middle and high school</td><td>1055 (52.3%)</td></tr><tr><td> College or higher</td><td>86 (4.3%)</td></tr><tr><td>Yearly household income (RMB)</td><td> </td></tr><tr><td> <10000</td><td>679 (33.7%)</td></tr><tr><td> 10000–15000</td><td>977 (48.4%)</td></tr><tr><td> >15000</td><td>362 (17.9%)</td></tr></table> |
9378b42cba512297ab323465c27429193f9a096a2bfe31c21e094e4e4b3721f5.png | simple | <table><tr><td>Item</td><td>Concentrate mix (%)</td><td>Rye straw (%)</td><td>BF-based silage<sup>2)</sup> (%)</td></tr><tr><td>Dry matter</td><td>87.9</td><td>90.0</td><td>58.3</td></tr><tr><td>Organic matter</td><td>91.7</td><td>95.4</td><td>88.5</td></tr><tr><td>Crude protein</td><td>16.4</td><td>4.2</td><td>16.9</td></tr><tr><td>Ether extract</td><td>2.5</td><td>0.2</td><td>3.9</td></tr><tr><td>Neutral detergent fiber</td><td>32.7</td><td>67.7</td><td>50.6</td></tr><tr><td>Acid detergent fiber</td><td>19.5</td><td>41.7</td><td>38.9</td></tr><tr><td>Hemicellulose</td><td>13.2</td><td>25.9</td><td>11.7</td></tr><tr><td>Crude fiber</td><td>11.3</td><td>37.8</td><td>31.2</td></tr><tr><td>Nitrogen free extracts</td><td>61.5</td><td>53.3</td><td>36.6</td></tr><tr><td>Crude ash</td><td>8.3</td><td>4.6</td><td>11.5</td></tr></table> |
47bc4c054e3d92e8494f5d5258653726d35d13749c00c22b99001cfab993a4bc.png | complex | <table><tr><td>Township</td><td>Population Density</td><td>Population</td><td colspan="4">Area Percentage of TRs > 10<sup>−5</sup></td><td colspan="4">Area Percentage of TRs > 10<sup>−4</sup></td></tr><tr><td></td><td>(Person/km<sup>2</sup>)</td><td>(Person)</td><td>F1</td><td>F2</td><td>F3</td><td>F4</td><td>F1</td><td>F2</td><td>F3</td><td>F4</td></tr><tr><td>Pingtong</td><td>3133.17</td><td>203,866</td><td>100.0%</td><td>87.4%</td><td>100.0%</td><td>100.0%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td></tr><tr><td>Linyuan</td><td>2182.87</td><td>70,476</td><td>100.0%</td><td>100.0%</td><td>100.0%</td><td>100.0%</td><td>100.0%</td><td>34.0%</td><td>42.6%</td><td>0.0%</td></tr><tr><td>Donggang</td><td>1638.03</td><td>48,262</td><td>100.0%</td><td>100.0%</td><td>100.0%</td><td>100.0%</td><td>13.6%</td><td>93.2%</td><td>100.0%</td><td>0.0%</td></tr><tr><td>Daliao</td><td>1565.19</td><td>111,191</td><td>85.7%</td><td>85.7%</td><td>85.7%</td><td>85.7%</td><td>34.7%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td></tr><tr><td>Chaozhou</td><td>1289.98</td><td>54,738</td><td>100.0%</td><td>71.7%</td><td>30.0%</td><td>20.0%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td></tr><tr><td>Linbian</td><td>1231.17</td><td>19,235</td><td>100.0%</td><td>100.0%</td><td>100.0%</td><td>100.0%</td><td>55.2%</td><td>89.7%</td><td>96.6%</td><td>0.0%</td></tr><tr><td>Sinyuan</td><td>957.74</td><td>36,692</td><td>100.0%</td><td>100.0%</td><td>100.0%</td><td>100.0%</td><td>65.2%</td><td>30.3%</td><td>54.6%</td><td>0.0%</td></tr><tr><td>Wandan</td><td>906.33</td><td>52,085</td><td>100.0%</td><td>100.0%</td><td>96.6%</td><td>100.0%</td><td>5.7%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td></tr><tr><td>Changzih</td><td>762.90</td><td>30,429</td><td>53.7%</td><td>43.3%</td><td>94.0%</td><td>70.2%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td></tr><tr><td>Linluo</td><td>695.76</td><td>11,313</td><td>100.0%</td><td>42.3%</td><td>100.0%</td><td>100.0%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td></tr><tr><td>Neipu</td><td>685.94</td><td>56,148</td><td>56.8%</td><td>45.5%</td><td>92.1%</td><td>23.9%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td></tr><tr><td>Jiadong</td><td>653.46</td><td>20,247</td><td>100.0%</td><td>100.0%</td><td>100.0%</td><td>100.0%</td><td>62.5%</td><td>35.4%</td><td>39.6%</td><td>0.0%</td></tr><tr><td>Dashu</td><td>644.81</td><td>43,190</td><td>98.2%</td><td>40.0%</td><td>96.4%</td><td>100.0%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td></tr><tr><td>Zhutian</td><td>609.46</td><td>17,719</td><td>100.0%</td><td>92.3%</td><td>57.7%</td><td>82.7%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td></tr><tr><td>Nanzhou</td><td>581.23</td><td>11,026</td><td>100.0%</td><td>100.0%</td><td>100.0%</td><td>100.0%</td><td>3.0%</td><td>48.5%</td><td>72.7%</td><td>0.0%</td></tr><tr><td>Jiouru</td><td>527.67</td><td>22,172</td><td>83.1%</td><td>49.4%</td><td>71.4%</td><td>84.4%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td></tr><tr><td>Kanding</td><td>523.70</td><td>16,374</td><td>97.6%</td><td>97.6%</td><td>90.5%</td><td>90.5%</td><td>7.1%</td><td>7.1%</td><td>33.3%</td><td>0.0%</td></tr><tr><td>Fangliao</td><td>441.36</td><td>25,482</td><td>98.7%</td><td>75.3%</td><td>98.7%</td><td>98.7%</td><td>42.9%</td><td>0.0%</td><td>0.0%</td><td>14.3%</td></tr><tr><td>Yanpu</td><td>413.82</td><td>26,629</td><td>27.9%</td><td>87.3%</td><td>26.6%</td><td>30.4%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td></tr><tr><td>Cishan</td><td>402.70</td><td>38,100</td><td>30.7%</td><td>59.1%</td><td>1.1%</td><td>11.4%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td></tr><tr><td>Ligang</td><td>389.06</td><td>26,814</td><td>52.1%</td><td>18.8%</td><td>7.3%</td><td>26.0%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td></tr><tr><td>Wanluan</td><td>344.43</td><td>20,918</td><td>55.7%</td><td>88.6%</td><td>67.1%</td><td>2.9%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td></tr><tr><td>Meinong</td><td>343.73</td><td>41,258</td><td>60.7%</td><td>77.4%</td><td>64.3%</td><td>29.8%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td></tr><tr><td>Gaoshu</td><td>283.08</td><td>25,520</td><td>5.5%</td><td>75.2%</td><td>61.5%</td><td>71.6%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>0.0%</td></tr><tr><td>Xinpi</td><td>173.39</td><td>10,232</td><td>98.8%</td><td>41.2%</td><td>83.5%</td><td>81.2%</td><td>0.0%</td><td>0.0%</td><td>2.4%</td><td>0.0%</td></tr><tr><td>Average</td><td>855.23</td><td>41,604.64</td><td>80.21%</td><td>75.12%</td><td>76.98%</td><td>72.38%</td><td>15.60%</td><td>13.53%</td><td>17.67%</td><td>0.57%</td></tr></table> |
cf768a9f8e968a50888bed7d41728b391cfa5da95794cefce572b6f0725007ff.png | simple | <table><tr><td>Linkage group</td><td>Length (cM)</td><td>Number of markers</td><td>Number of bins</td><td>Largest gap (cM)</td><td>Mean gap size (cM)</td></tr><tr><td>LG1</td><td>479.62</td><td>999</td><td>196</td><td>16.70</td><td>2.46</td></tr><tr><td>LG2</td><td>475.13</td><td>1032</td><td>242</td><td>17.87</td><td>1.97</td></tr><tr><td>LG3</td><td>422.07</td><td>883</td><td>194</td><td>9.46</td><td>2.19</td></tr><tr><td>LG4</td><td>378.83</td><td>952</td><td>188</td><td>13.59</td><td>2.03</td></tr><tr><td>LG5</td><td>373.16</td><td>765</td><td>166</td><td>14.89</td><td>2.26</td></tr><tr><td>LG6</td><td>369.61</td><td>882</td><td>176</td><td>15.41</td><td>2.11</td></tr><tr><td>LG7</td><td>346.04</td><td>768</td><td>151</td><td>16.73</td><td>2.31</td></tr><tr><td>LG8</td><td>295.54</td><td>599</td><td>132</td><td>14.47</td><td>2.26</td></tr><tr><td>LG9</td><td>291.43</td><td>725</td><td>135</td><td>14.55</td><td>2.17</td></tr><tr><td>LG10</td><td>270.71</td><td>655</td><td>114</td><td>16.40</td><td>2.40</td></tr><tr><td>LG11</td><td>257.19</td><td>554</td><td>114</td><td>13.72</td><td>2.28</td></tr><tr><td>LG12</td><td>252.32</td><td>520</td><td>126</td><td>13.29</td><td>2.02</td></tr><tr><td>LG13</td><td>238.96</td><td>678</td><td>125</td><td>15.32</td><td>1.93</td></tr><tr><td>LG14</td><td>229.81</td><td>457</td><td>99</td><td>11.53</td><td>2.35</td></tr><tr><td>LG15</td><td>227.36</td><td>659</td><td>122</td><td>11.09</td><td>1.88</td></tr><tr><td>LG16</td><td>176.71</td><td>400</td><td>83</td><td>14.44</td><td>2.16</td></tr><tr><td>LG17</td><td>159.37</td><td>293</td><td>78</td><td>16.55</td><td>2.07</td></tr><tr><td>LG18</td><td>130.74</td><td>265</td><td>63</td><td>7.99</td><td>2.11</td></tr><tr><td>LG19</td><td>111.63</td><td>276</td><td>52</td><td>11.50</td><td>2.19</td></tr><tr><td>LG20</td><td>100.27</td><td>273</td><td>53</td><td>14.37</td><td>1.93</td></tr><tr><td>LG21</td><td>63.56</td><td>199</td><td>31</td><td>12.62</td><td>2.12</td></tr><tr><td>LG22</td><td>60.07</td><td>123</td><td>24</td><td>10.00</td><td>2.61</td></tr><tr><td>LG23</td><td>48.62</td><td>113</td><td>27</td><td>4.30</td><td>1.87</td></tr><tr><td>LG24</td><td>38.49</td><td>94</td><td>16</td><td>8.79</td><td>2.57</td></tr><tr><td>LG25</td><td>26.81</td><td>85</td><td>22</td><td>5.08</td><td>1.28</td></tr><tr><td>LG26</td><td>20.17</td><td>91</td><td>15</td><td>4.03</td><td>1.44</td></tr><tr><td>LG27</td><td>15.99</td><td>72</td><td>12</td><td>4.03</td><td>1.45</td></tr><tr><td>TOTAL</td><td>5860.21</td><td>13,412</td><td>2756</td><td></td><td></td></tr></table> |
20e1b61d86c99734872acc27bef4e1ede7c86eb2ff77c4af8bab2b4fb022bc30.png | complex | <table><tr><td rowspan="2">Collection time</td><td colspan="4">Pollen viability (%)</td></tr><tr><td>A</td><td>G</td><td>M</td><td>Q</td></tr><tr><td>05:00–06:00</td><td>20.2 ± 1.1a</td><td>16.2 ± 1.2a</td><td>11.9 ± 2.1a</td><td>15.5 ±1.6a</td></tr><tr><td>06:00–07:00</td><td>15.9 ± 0.5b</td><td>11.4 ± 0.8b</td><td>6.7 ± 0.9b</td><td>9.1 ± 1.0b</td></tr><tr><td>07:00–08:00</td><td>10.3 ± 0.9c</td><td>7.3 ± 0.6c</td><td>4.1 ± 0.3c</td><td>4.8 ± 0.6c</td></tr></table> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.